{"id":3474,"date":"2017-05-09T16:42:03","date_gmt":"2017-05-09T07:42:03","guid":{"rendered":"http:\/\/www.m.ehime-u.ac.jp\/school\/radiology\/contents\/?p=3474"},"modified":"2017-05-09T16:42:03","modified_gmt":"2017-05-09T07:42:03","slug":"2016%e5%b9%b4%e6%a5%ad%e7%b8%be%e3%80%80%e3%81%9d%e3%81%ae2","status":"publish","type":"post","link":"https:\/\/www.m.ehime-u.ac.jp\/school\/radiology\/%e7%a0%94%e7%a9%b6%e7%b4%b9%e4%bb%8b\/3474\/","title":{"rendered":"2016\u5e74\u696d\u7e3e\u3000\u305d\u306e2"},"content":{"rendered":"

2016\u5e74\u696d\u7e3e\u3000\u305d\u306e2
\n\u25a0\u3000\u5b66\u4f1a\u30fb\u7814\u7a76\u4f1a\u767a\u8868
\n\u56fd\u5185\u5b66\u4f1a\uff08\u5168\u56fd\uff09<\/a>
\n\u56fd\u5185\u5b66\u4f1a\uff08\u5730\u65b9\u4f1a\uff09<\/a>
\n\u25a0 \u8b1b\u6f14<\/a>
\n\u25a0 \u7814\u7a76\u52a9\u6210<\/a>
\n\u25a0 \u53d7\u8cde<\/a>
\n\u8ad6\u6587\u3001\u56fd\u969b\u5b66\u4f1a\u767a\u8868\u306f2016\u5e74\u696d\u7e3e\u3000\u305d\u306e1<\/a>\u3092\u3054\u89a7\u4e0b\u3055\u3044\u3002
\n—————————
\n\u25a0<\/span> \u5b66\u4f1a\u767a\u8868(\u56fd\u5185)<\/strong>
\n<\/a>\u25cf<\/span> \u56fd\u5185\u5b66\u4f1a(\u5168\u56fd)
\n1.Fukuyama N, Kido Te, Uetani T, Tanabe Y, Yokoi T, Ogawa R, Tashiro R, Kido To, Kurata A, Miyagawa M, Mochizuki T. Myocardial Blood Flow with Myocardial Segmentation of the Area at Risk Based on Stress Dynamic Perfusion Computed Tomography: Validation by Using Fractional Flow Reserve. \u7b2c75\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u7dcf\u4f1a\uff082016. 4, \u6a2a\u6d5c\uff09
\n2.Kawaguchi N, Kikuchi T, Fukuyama N, Kido Te, Inoue T, Miki H, Mochiduki T et al. Myocardial area at risk for coronary CT angiography using Voronoi algorithm-based myocardial segmentation in comparison with 13N-ammonia PET. \u7b2c75\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u7dcf\u4f1a\uff082016. 4, \u6a2a\u6d5c\uff09
\n3.Nishijima N, Hamamoto Y, Nagasaki K, Kanzaki H, Mochizuki T, Kataoka M, Nishikawa A, Uwatsu K, Tsuruoka S. Pericardial effusion after chemoradiotherapy for esophageal cancer. \u7b2c29\u56de\u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a JASTRO\uff082016. 11, \u4eac\u90fd\uff09
\nNishikawa A, Tsuruoka S, Uwatsu K, Kataoka M. Treatment results of the radiotherapy combined with cetuximab for head and neck cancer. \u7b2c29\u56de\u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a JASTRO\uff082016. 11, \u4eac\u90fd\uff09
\n4.Ogawa R, Kido To, Nakamura M, Kido Te, Mochizuki T, Higaki T. Asymmetry of pulmonary perfusion and pulmonary regurgitation in Tetralogy of Fallot after repair. \u7b2c44\u56de\u65e5\u672c\u78c1\u6c17\u5171\u9cf4\u533b\u5b66\u4f1a\u5927\u4f1a\uff082016. 9, \u57fc\u7389\uff09
\n5.Ogawa R, Kido To, Yokoi T, Fukuyama N, Tanabe Y, Tashiro R, Kido Te, Kurata A, Miyagawa M, Mochizuki T. Quantitative Circumferential Strain Analysis using 3-Tesla Feature-tracking cardiovascular magnetic resonance in patients with old myocardial infarction. \u7b2c75\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u7dcf\u4f1a\uff082016. 4, \u6a2a\u6d5c\uff09
\n6.Ogawa R, Kido To, Okizuka Y, Kido Te, Kurata A, Miyagawa M, Mochizuki T, Ogimoto A. Quantitative Circumferential Strain Analysis Using 3-Tesla Feature-Tracking Cardiovascular Magnetic Resonance in Patients with Old Myocardial Infarction. \u7b2c80\u56de\u65e5\u672c\u5faa\u74b0\u5668\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a \uff082016. 3, \u4ed9\u53f0\uff09
\n7.Ogawa R, Kido To, Okizuka Y, Kido Te, Kurata A, Miyagawa M, Mochizuki T, Ogimoto A. T1 Mapping Using a Saturation Recovery Single-Shot Acquisition at 3 Tesla MRI in Differentiation of Normal Myocardium from Hypertrophic Cardiomyopathy. \u7b2c80\u56de\u65e5\u672c\u5faa\u74b0\u5668\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff082016. 3, \u4ed9\u53f0\uff09
\n8.Senoo A, Yamamoto H, Kitagawa T, Kurisu S, Kihara Y, Tatsugami F, Awai K, Higashino H. Usefulness of Calcium Subtraction Coronary Computed Tomography Angiography: Compared with Stress Myocardial Perfusion SPECT. \u7b2c80\u56de\u65e5\u672c\u5faa\u74b0\u5668\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff082016. 3, \u4ed9\u53f0\uff09
\nTanabe Y, Kido Te, Kurata A, Kouchi T, Fukuyama N, Yokoi T, Kido To, Miyagawa M, Mochizuki T, et al. Impact of Myocardial Late Iodine Enhancement Computed Tomography Imaging with Model-Based Iterative Reconstruction. \u7b2c64\u56de\u65e5\u672c\u5fc3\u81d3\u75c5\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff082016. 9, \u6771\u4eac\uff09
\n9.Tanabe Y, Kido Te, Yokoi T, Fukuyama N, Kurata A, Ogawa R, Yokoyama R, Kido To, Miyagawa M, Mochizuki T. Quantitative Assessment of Left Ventricular Three-Dimensional Maximum Principal Strain using Cardiac Computed Tomography for Identification of Myocardial Infarction. \u7b2c75\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u7dcf\u4f1a\uff082016. 4, \u6a2a\u6d5c\uff09
\n10.Tsuda T, Koiwahara G, Hirata M, Tanaka H, Mochizuki T. Are There Any Subtle Clues to Detect Pancreatic Adenocarcinoma on Previous Abdominal CT before Initial Diagnosis ? \u7b2c75\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u7dcf\u4f1a\uff082016. 4, \u6a2a\u6d5c\uff09
\n11.\u4e95\u624b\u9999\u5948, \u671b\u6708\u8f1d\u4e00, \u5ca1\u5d0e\u5e79\u751f, \u91cd\u677e\u4e45\u4e4b, \u4f50\u91ce\u7531\u6587, \u6c34\u91ce\u6d0b\u8f14. \u80ba\u52d5\u8108\u7624\u3092\u5408\u4f75\u3057\u305f \u80ba\u52d5\u8108\u5185\u819c\u8089\u816b\u306e1\u4f8b. \u7b2c30\u56de\u80f8\u90e8\u653e\u5c04\u7dda\u7814\u7a76\u4f1a\uff082016. 9, \u6771\u4eac\uff09
\n12.\u6a2a\u5c71\u9686, \u9ad8\u7551\u656c\u4e4b, \u5927\u4e80\u771f\u4e00, \u5c0f\u677e\u6b63\u660e, \u767d\u5c71\u88d5\u5b50, \u7af9\u539f\u548c\u5b8f, \u83c5\u539f\u656c\u6587, \u7247\u5ca1\u6b63\u660e. \u5b50\u5bae\u9838\u764cIIB\u671f\u6241\u5e73\u4e0a\u76ae\u764c\u306e\u6cbb\u7642\u6210\u7e3e\u3068\u518d\u767a\u30ea\u30b9\u30af\u56e0\u5b50 Treatment outcome and recurrence risk factors of the patients with stage IIB uterine cervical squamous cell carcinoma. \u764c\u6cbb\uff082016. 10, \u6a2a\u6d5c\uff09
\n13.\u5ca1\u7530\u77e5\u4e45, \u5bae\u5ddd\u6b63\u7537, \u6e21\u90e8\u7b11\u9e97, \u7530\u4ee3\u3089\u307f, \u897f\u5c71\u9999\u5b50, \u671b\u6708\u8f1d\u4e00. \u82e5\u624b\u7814\u7a76\u8005\u306e\u63cf\u304f\u672a\u6765\u50cf\u300c\u907a\u4f1d\u5b50\u6cbb\u7642\u3068\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u300d \u7b2c5\u56de\u5206\u5b50\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u590f\u5b63\u96c6\u4e2d\u30bb\u30df\u30ca\u30fc\uff082016. 7, \u4eac\u90fd\uff09
\n14.\u5409\u7530\u548c\u6a39, \u80fd\u7530\u7d17\u4ee3, \u4e09\u6728\u5747. \u30ed\u30bf\u30a6\u30a3\u30eb\u30b9\u8178\u708e\u306b\u3088\u308b\u4e00\u904e\u6027\u8133\u6881\u81a8\u5927\u90e8\u75c5\u5909\u53ca\u3073\u6025\u6027\u5c0f\u8133\u708e\u306e\u4e00\u4f8b. \u7b2c36\u56de\u795e\u7d4c\u653e\u5c04\u7dda\u30ef\u30fc\u30af\u30b7\u30e7\u30c3\u30d7.\uff082016. 7, \u91d1\u6ca2\uff09
\n15.\u5bae\u5ddd\u6b63\u7537, \u6e21\u90e8\u7b11\u9e97, \u897f\u5c71\u9999\u5b50, \u7530\u4ee3\u3089\u307f, \u5c0f\u5ddd\u907c, \u7530\u908a\u88d5\u8cb4, \u4e2d\u6751\u58ee\u5fd7, \u57ce\u6238\u502b\u4e4b, \u57ce\u6238\u8f1d\u4ec1, \u5e73\u585a\u7fa9\u5eb7, \u671b\u6708\u8f1d\u4e00. \u534a\u5c0e\u4f53\u30c0\u30a4\u30ca\u30df\u30c3\u30afSPECT\u3092\u7528\u3044\u305fTc-99m\u5fc3\u7b4b\u8840\u6d41\u4e88\u5099\u80fd\u306e\u81e8\u5e8a\u8a55\u4fa1.\uff082016. 11, \u540d\u53e4\u5c4b\uff09
\n16.\u5bae\u5ddd\u6b63\u7537. \u30b7\u30f3\u30dd\u30b8\u30a6\u30e0 Integrated Diagnostic Imaging of Cardiac Disease 2. Recent advances and increasing importance of cardiac SPECT and PET. \u7b2c75\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u7dcf\u4f1a\uff082016. 4, \u6a2a\u6d5c\uff09
\n16.\u5bae\u5ddd\u6b63\u7537. \u30b7\u30f3\u30dd\u30b8\u30a6\u30e0 \u30de\u30eb\u30c1\u30e2\u30c0\u30ea\u30c6\u30a3\u6642\u4ee3\u306b\u304a\u3051\u308b\u5fc3\u7b4b\u8840\u6d41\u30fb\u8840\u6d41\u4e88\u5099\u80fd\u306e\u5b9a\u91cf\u8a55 \u534a\u5c0e\u4f53SPECT\u3092\u7528\u3044\u305fTc-99m\u5fc3\u7b4b\u8840\u6d41\u4e88\u5099\u80fd\u306e\u5b9a\u91cf\u8a55\u4fa1. \u7b2c26\u56de\u65e5\u672c\u5fc3\u81d3\u6838\u533b\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u5927\u4f1a.\uff082016. 7, \u6d25\uff09
\n17.\u5bae\u5185\u7b11\u9e97, \u5bae\u5ddd\u6b63\u7537, \u77f3\u6751\u96bc\u4eba, \u897f\u5c71\u9999\u5b50, \u7530\u4ee3\u3089\u307f, \u671b\u6708\u8f1d\u4e00. D530c\u30c0\u30a4\u30ca\u30df\u30c3\u30af\u65e9\u671fSPECT(5-10\u5206)\u306860\u5206\u5f8cSPECT\u753b\u50cf\u306e\u6bd4\u8f03. \u7b2c8\u56deCZT\u7814\u7a76\u4f1a\uff0e\uff082016. 5, \u5929\u738b\u6d32\uff09
\n18.\u5bae\u5185\u7b11\u9e97, \u5bae\u5ddd\u6b63\u7537, \u77f3\u6751\u96bc\u4eba, \u671b\u6708\u8f1d\u4e00. \u5fc3\u81d3\u5c02\u7528\u534a\u5c0e\u4f53\u88c5\u7f6e\u306b\u3088\u308b\u30c0\u30a4\u30ca\u30df\u30c3\u30af\u53ce\u96c6SPECT\u753b\u50cf\u306e\u691c\u8a0e. \u7b2c26\u56de\u65e5\u672c\u5fc3\u81d3\u6838\u533b\u5b66\u4f1a\u7dcf\u4f1a\u2022\u5b66\u8853\u5927\u4f1a\uff0e\uff082016. 7, \u6d25\uff09
\n19.\u5bae\u5185\u7b11\u9e97\uff0c\u5bae\u5ddd\u6b63\u7537\uff0c\u77f3\u6751\u96bc\u4eba\uff0c\u671b\u6708\u8f1d\u4e00\uff0e\u5fc3\u81d3\u5c02\u7528\u534a\u5c0e\u4f53\u88c5\u7f6e\u306b\u3088\u308b\u30c0\u30a4\u30ca\u30df\u30c3\u30af\u53ce\u96c6SPECT\u753b\u50cf\u306e\u691c\u8a0e. \u7b2c56\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a\uff0e\uff082016. 11, \u540d\u53e4\u5c4b\uff09
\n20.\u5bae\u5185\u7b11\u9e97, \u5bae\u5ddd\u6b63\u7537, \u7530\u4ee3\u3089\u307f, \u897f\u5c71\u9999\u5b50, \u671b\u6708\u8f1d\u4e00. \u5fc3\u81d3FDG PET&\u534a\u5c0e\u4f53SPECT. \u7b2c5\u56de\u5206\u5b50\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u590f\u5b63\u96c6\u4e2d\u30bb\u30df\u30ca\u30fc\uff0e\uff082016. 7, \u4eac\u90fd\uff09
\n21.\u5bae\u5185\u7b11\u9e97, \u7530\u908a\u88d5\u8cb4, \u6a2a\u4e95\u656c\u5f18, \u798f\u5c71\u76f4\u7d00, \u57ce\u6238\u8f1d\u4ec1, \u5009\u7530\u8056, \u5ddd\u53e3\u76f4\u4eba, \u4e09\u6728\u5747, \u671b\u6708\u8f1d\u4e00\uff0e Characterization of normal regional left ventricular three-dimensional maximum principal strain by cardiac computed tomography. \u7b2c75\u56de\u65e5\u672c\u653e\u5c04\u7dda\u5b66\u4f1a\u7dcf\u4f1a\uff0e\uff082016. 4, \u6a2a\u6d5c\uff09
\n22.\u7d30\u5ddd\u6d69\u5e73, \u5fb3\u5897\u660e\u6587, \u53ea\u4fe1\u7f8e\u7d00, \u5fb3\u6c38\u4f38\u5b50, \u6850\u5c71\u90c1\u5b50, \u6e05\u6c34\u8f1d\u5f66, \u9152\u4e95\u4f38\u4e5f, \u83c5\u539f\u656c\u6587, \u7af9\u539f\u548c\u5b8f, \u6a2a\u5c71\u9686, \u767d\u5c71\u88d5\u5b50, \u5c0f\u677e\u6b63\u660e, \u5927\u4e80\u771f\u4e00, \u5bfa\u672c\u5178\u5f18. \u5b50\u5bae\u8089\u816b\u306eFDG-PET\/CT\u6240\u898b. \u7b2c52\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u79cb\u5b63\u81e8\u5e8a\u5927\u4f1a.\uff082016. 9, \u6771\u4eac\uff09
\n23.\u9e7f\u5cf6\u6587, \u5ddd\u6761\u6587\u9686, \u6771\u91ce\u535a, \u8c9e\u5fb3\u307f\u3061\u3053, \u795e\u7530\u606d\u5b50, \u5ba4\u91ce\u4e09\u548c\u5b50, \u7530\u4e2d\u653f\u884c, \u6c60\u6c34\u6681\u5f66, \u4e2d\u7530\u8302, \u4f0a\u7530\u52dd\u5178, \u85e4\u679d\u88d5\u4e4b, \u963f\u90e8\u5145\u4f2f. \u30a2\u30c6\u30ce\u30b7\u30f3\u8ca0\u8377\u306b\u3088\u308b\u5fc3\u62cd\u6570\u4e0a\u6607\u306e\u306a\u3044\u75c7\u4f8b\u306e\u691c\u8a0e -\u8ca0\u8377\u5fc3\u7b4b\u8840\u6d41\u30b7\u30f3\u30c1\u30b0\u30e9\u30d5\u30a3\u30fc\u3092\u7528\u3044\u3066-. \u7b2c64\u56de\u65e5\u672c\u5fc3\u81d3\u75c5\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a.\uff082016. 9, \u6771\u4eac\uff09
\n24.\u5c0f\u91ce\u525b\u53f2\uff0c\u53ea\u4fe1\u7f8e\u7d00\uff0c\u9152\u4e95\u4f38\u4e5f\uff0c\u83c5\u539f\u656c\u6587\uff0e\u691c\u5b9a\u91cf555MBq\u3092\u7528\u3044\u305f\u9aa8\u30b7\u30f3\u30c1\u30b0\u30e9\u30d5\u30a3\u306eWB\u30ab\u30a6\u30f3\u30c8\u306b\u5f71\u97ff\u3092\u4e0e\u3048\u308b\u56e0\u5b50\u306e\u691c\u8a0e\uff0e\u7b2c56\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a.\uff082016. 11, \u540d\u53e4\u5c4b\uff09
\n25.\u677e\u7530\u6075, \u4e09\u6728\u5747, \u68ee\u5343\u5c0b, \u6751\u4e0a\u5fe0\u53f8, \u4e95\u4e0a\u6b66. \u81b5\u7c98\u6db2\u764c\u306e\u4e00\u5207\u9664\u4f8b. \u7b2c30\u56de\u65e5\u672c\u8179\u90e8\u653e\u5c04\u7dda\u5b66\u4f1a.\uff082016. 6, \u91d1\u6ca2\uff09
\n26.\u677e\u7530\u6075, \u6d25\u7530\u5b5d\u6cbb. \u30a4\u30e1\u30fc\u30b8\u30a4\u30f3\u30bf\u30fc\u30d7\u30ea\u30c6\u30fc\u30b7\u30e7\u30f3 \u89e3\u7b54\u30fb\u89e3\u8aac \u5a66\u4eba\u79d1\u30fb\u6ccc\u5c3f\u5668\u75c7\u4f8b. \u7b2c52\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u79cb\u5b63\u81e8\u5e8a\u5927\u4f1a.\uff082016. 09, \u6771\u4eac\uff09
\n27.\u795e\ufa11\u535a\u5145, \u6ff1\u672c\u6cf0, \u9577\ufa11\u6167, \u4e95\u4e0a\u6b66, \u897f\u5cf6\u7d00\u5b50, \u671b\u6708\u8f1d\u4e00. \u5f53\u9662\u3067\u7d4c\u9a13\u3057\u305f\u76f4\u8178\u5185\u5bb9\u30b3\u30f3\u30c8\u30ed\u30fc\u30eb\u4e0d\u826f\u306e\u524d\u7acb\u817a\u764cIMRT\u75c7\u4f8b\u306b\u304a\u3051\u308b\u5b9f\u969b\u306e\u76f4\u8178\u7dda\u91cf. \u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a\u7b2c29\u56de\u5b66\u8853\u5927\u4f1a.\uff082016. 11, \u4eac\u90fd\uff09
\n28.\u6e05\u6c34\u8f1d\u5f66, \u5fb3\u5897\u660e\u6587, \u53ea\u4fe1\u7f8e\u7d00, \u7d30\u5ddd\u6d69\u5e73, \u5fb3\u6c38\u4f38\u5b50, \u6850\u5c71\u90c1\u5b50, \u9152\u4e95\u4f38\u4e5f, \u83c5\u539f\u656c\u6587, \u6e05\u85e4\u4f50\u77e5\u5b50, \u9ad8\u6a4b\u4e09\u5948, \u539f\u6587\u5805, \u9ad8\u5d8b\u6210\u8f1d, \u9752\u5100\u5065\u4e8c\u90ce, \u5927\u4f4f\u7701\u4e09, \u897f\u6751\u7406\u6075\u5b50. \u4e73\u7ba1\u5185\u764c\u3092\u5408\u4f75\u3057\u305f\u4e73\u817a\u6241\u5e73\u4e0a\u76ae\u764c\u306e1\u4f8b. \u7b2c52\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u79cb\u5b63\u81e8\u5e8a\u5927\u4f1a.\uff082016. 9, \u6771\u4eac\uff09
\n29.\u897f\u5cf6\u7d00\u5b50, \u7d30\u5ddd\u6d69\u5e73, \u53ea\u4fe1\u7f8e\u7d00, \u6850\u5c71\u90c1\u5b50, \u6e05\u6c34\u8f1d\u5f66, \u9ad8\u6a4b\u5fe0\u7ae0, \u9152\u4e95\u4f38\u4e5f, \u83c5\u539f\u656c\u6587, \u7d30\u5ddd\u5fe0\u5ba3, \u6a4b\u6839\u52dd\u7fa9, \u9ad8\u7551\u6d69\u4e4b, \u5bfa\u672c\u5178\u5f18. \u304c\u3093\u30c9\u30c3\u30af\u3067\u898b\u3064\u304b\u3063\u305f\u5f8c\u814e\u6027\u817a\u816b\u306e1\u4f8b. \u7b2c30\u56de\u65e5\u672c\u8179\u90e8\u653e\u5c04\u7dda\u5b66\u4f1a.\uff082016. 6, \u91d1\u6ca2\uff09
\n30.\u897f\u5cf6\u7d00\u5b50, \u6ff1\u672c\u6cf0, \u9577\ufa11\u6167, \u795e\ufa11\u535a\u5145, \u671b\u6708\u8f1d\u4e00, \u7247\u5ca1\u6b63\u660e, \u897f\u5ddd\u6566, \u4e0a\u6d25\u5b5d\u592a\u90ce, \u974d\u5ca1\u614e\u592a\u90ce. \u98df\u9053\u764c\u5316\u5b66\u653e\u5c04\u7dda\u7642\u6cd5\u5f8c\u306e\u5fc3\u56a2\u6db2\u8caf\u7559. \u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a\u7b2c29\u56de\u5b66\u8853\u5927\u4f1a.\uff082016. 11, \u4eac\u90fd\uff09
\n31.\u5ddd\u53e3\u76f4\u4eba, \u7530\u4ee3\u3089\u307f, \u4e95\u4e0a\u6b66, \u4e09\u6728\u5747, \u4ed6. N-13\u30a2\u30f3\u30e2\u30cb\u30a2PET\u5fc3\u7b4b\u8840\u6d41\u5b9a\u91cf\u8a55\u4fa1\u306b\u3088\u308b\u865a\u8840\u6027\u75c5\u5909\u306e\u8a3a\u65ad\u80fd. \u7b2c26\u56de\u65e5\u672c\u5fc3\u81d3\u6838\u533b\u5b66\u5b66\u4f1a\u7dcf\u4f1a.\uff082016. 7, \u6d25\uff09
\n32.\u5ddd\u53e3\u76f4\u4eba, \u83ca\u6c60\u9686\u5fb3, \u4e09\u6728\u5747, \u4ed6. Diagnostic Performance of Quantitative Assessment of 13N-ammmonia PET for the Detection of Obstructive Coronary Artery Disease. \u7b2c80\u56de\u65e5\u672c\u5faa\u74b0\u5668\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a.\uff082016. 3, \u4ed9\u53f0\uff09
\n33.\u5ddd\u53e3\u76f4\u4eba, \u83ca\u6c60\u9686\u5fb3, \u798f\u5c71\u76f4\u7d00, \u57ce\u6238\u8f1d\u4ec1, \u671b\u6708\u8f1d\u4e00, \u4ed6. \u5fc3\u81d3CT\u3092\u7528\u3044\u305f\u51a0\u52d5\u8108\u652f\u914d\u704c\u6d41\u57df\u89e3\u6790\u30bd\u30d5\u30c8\u3068\u30a2\u30f3\u30e2\u30cb\u30a2PET\u306b\u3088\u308b\u865a\u8840\u9818\u57df\u306e\u691c\u8a0e. \u7b2c26\u56de\u65e5\u672c\u5fc3\u8840\u7ba1\u753b\u50cf\u52d5\u614b\u5b66\u4f1a.\uff082016. 1, \u6771\u4eac\uff09
\n34.\u5ddd\u53e3\u76f4\u4eba, \u77f3\u4e38\u826f\u5e83, \u6751\u4e0a\u5fe0\u53f8, \u4e09\u6728\u5747, \u7530\u4e2d\u5b8f\u660e. CT\u306b\u57fa\u3065\u3044\u305f\u5916\u50b7\u6027\u813e\u640d\u50b7\u306b\u304a\u3051\u308b\u6cbb\u7642\u65b9\u6cd5\u9078\u629e\u306e\u691c\u8a0e. \u7b2c45\u56de\u65e5\u672cIVR\u5b66\u4f1a\u7dcf\u4f1a.\uff082016. 5, \u540d\u53e4\u5c4b\uff09
\n35.\u5ddd\u6761\u6587\u9686, \u9e7f\u5cf6\u6587, \u6771\u91ce\u535a, \u7530\u4e2d\u653f\u884c, \u6c60\u6c34\u6681\u5f66, \u4e2d\u7530\u8302, \u4f0a\u7530\u52dd\u5178, \u8c9e\u5fb3\u307f\u3061\u3053, \u795e\u7530\u606d\u5b50, \u5ba4\u91ce\u4e09\u548c\u5b50, \u85e4\u679d\u88d5\u4e4b, \u963f\u90e8\u5145\u4f2f. \u55ab\u7159\u306b\u3088\u308b\u5fc3\u7b4b\u3078\u306e\u5f71\u97ff\u306b\u3064\u3044\u3066 -\u6b63\u5e38\u51a0\u52d5\u8108\u75c7\u4f8b\u3092\u5bfe\u8c61\u3068\u3057\u305f\u691c\u8a0e-. \u7b2c64\u56de\u65e5\u672c\u5fc3\u81d3\u75c5\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a.\uff082016. 9, \u6771\u4eac\uff09
\n36.\u53ea\u4fe1\u7f8e\u7d00, \u7d30\u5ddd\u6d69\u5e73, \u6850\u5c71\u90c1\u5b50, \u6e05\u6c34\u8f1d\u5f66, \u9ad8\u6a4b\u5fe0\u7ae0, \u9152\u4e95\u4f38\u4e5f, \u83c5\u539f\u656c\u6587, \u897f\u5cf6\u7d00\u5b50, \u7247\u5ca1\u6b63\u660e, \u9ad8\u7551\u656c\u4e4b, \u5c0f\u677e\u6b63\u660e, \u7af9\u539f\u548c\u5b8f, \u9ad8\u7551\u6d69\u4e4b, \u5bfa\u672c\u5178\u5f18. \u5b50\u5bae\u9838\u764c\u540c\u6642\u5316\u5b66\u653e\u5c04\u7dda\u7642\u6cd5\u5f8c\u306b\u767a\u75c7\u3057\uff0c\u8a3a\u65ad\u306b\u82e6\u616e\u3057\u305f\u8179\u819c\u60aa\u6027\u4e2d\u76ae\u816b\u306e1\u4f8b. \u7b2c30\u56de\u65e5\u672c\u8179\u90e8\u653e\u5c04\u7dda\u5b66\u4f1a.\uff082016. 6, \u91d1\u6ca2\uff09
\n37.\u53ea\u4fe1\u7f8e\u7d00, \u5fb3\u5897\u660e\u6587, \u7d30\u5ddd\u6d69\u5e73, \u6e05\u6c34\u8f1d\u5f66, \u9152\u4e95\u4f38\u4e5f, \u83c5\u539f\u656c\u6587, \u82b1\u5ddd\u6d69\u4e4b, \u9580\u7530\u4f38\u4e5f, \u9ad8\u7551\u6d69\u4e4b, \u4e95\u4e0a\u6b66. FDG-PET\/CT\u304c\u539f\u767a\u5de3\u306e\u8a3a\u65ad\u306b\u6709\u7528\u3067\u3042\u3063\u305f\u6241\u6843\u764c\u306e1\u4f8b. \u7b2c56\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a.\uff082016. 11, \u540d\u53e4\u5c4b\uff09
\n38.\u53ea\u4fe1\u7f8e\u7d00, \u5fb3\u5897\u660e\u6587, \u7d30\u5ddd\u6d69\u5e73, \u5fb3\u6c38\u4f38\u5b50, \u6850\u5c71\u90c1\u5b50, \u6e05\u6c34\u8f1d\u5f66, \u9152\u4e95\u4f38\u4e5f, \u83c5\u539f\u656c\u6587, \u5c0f\u677e\u6b63\u660e, \u7af9\u539f\u548c\u5b8f, \u5bfa\u672c\u5178\u5f18. \u753b\u50cf\u8a55\u4fa1\u304c\u56f0\u96e3\u3067\u3042\u3063\u305f\u6f3f\u6db2\u6027\u5b50\u5bae\u5185\u819c\u4e0a\u76ae\u764c\u4e3b\u4f53\u306e\u6f3f\u6db2\u6027\u817a\u764c\u306e1\u4f8b. JSAWI2016, 17th Annual Symposium.\uff082016. 9, \u6de1\u8def\uff09
\n39.\u7af9\u53e3\u5d07, \u4e95\u4e0a\u7950\u99ac, \u5ca9\u6751\u5353\u660e, \u4e2d\u5cf6\u76f4\u7f8e, \u798f\u4e95\u8061. \u8179\u90e8\u816b\u7624\u306e\u7531\u6765\u8a3a\u65ad\u306b\u3064\u3044\u3066. \u7b2c52\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u79cb\u5b63\u81e8\u5e8a\u5927\u4f1a.\uff082016. 9, \u6771\u4eac\uff09
\n40.\u4e09\u6728\u5747, \u68ee\u5343\u5c0b, \u4e95\u4e0a\u6b66, \u83ca\u6c60\u9686\u5fb3, \u5ca1\u672c\u61b2\u7701, \u6cb3\u91ce\u517c\u4e45, \u5e73\u585a\u7fa9\u5eb7, \u83ca\u6c60\u6075\u4e00. \u4e2d\u5927\u8133\u8108\u9818\u57df\u306e\u6025\u6027\u671f\u8133\u6897\u585e\u306b\u304a\u3051\u308b3D ASL\uff1aArterial Transit Artifact\u306e\u8a55\u4fa1. \u7b2c45\u56de\u65e5\u672c\u795e\u7d4c\u653e\u5c04\u7dda\u5b66\u4f1a.\uff082016. 2, \u5c71\u5f62\uff09
\n41.\u4e2d\u5cf6\u76f4\u7f8e, \u5c0f\u53e3\u6b63\u5f66, \u718a\u4e95\u5eb7\u5b50, \u5409\u7530\u5321\u5b8f. \u8853\u524d\u306b\u5316\u5b66\u7642\u6cd5\u3092\u65bd\u884c\u3057\u305f\u4e73\u623f\u5207\u9664\u8853\u5f8c\u653e\u5c04\u7dda\u6cbb\u7642\u75c7\u4f8b\u306e\u6cbb\u7642\u6210\u7e3e\u3068\u4e88\u5f8c\u56e0\u5b50\u306b\u95a2\u3059\u308b\u691c\u8a0e. \u7b2c24\u56de\u65e5\u672c\u4e73\u764c\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a.\uff082016. 6, \u6771\u4eac\uff09
\n42.\u6d25\u7530\u5b5d\u6cbb, \u677e\u7530\u6075, \u671b\u6708\u8f1d\u4e00, \u6c34\u91ce\u6d0b\u8f14, \u5317\u6fa4\u7406\u5b50, \u5317\u6fa4\u8358\u5e73, \u6c34\u672c\u54f2\u4e5f, \u9ad8\u7530\u6cf0\u6b21. \u81b5\u7c98\u6db2\u764c\u306e\u4e00\u4f8b. \u7b2c30\u56de\u65e5\u672c\u8179\u90e8\u653e\u5c04\u7dda\u5b66\u4f1a.\uff082016. 6, \u91d1\u6ca2\uff09
\n43.\u7530\u4ee3\u3089\u307f, \u5bae\u5ddd\u6b63\u7537, \u5bae\u5185\u7b11\u9e97, \u5ddd\u53e3\u76f4\u4eba, \u77f3\u4e38\u826f\u5e83, \u4e95\u4e0a\u6b66, \u4e09\u6728\u5747, \u671b\u6708\u8f1d\u4e00. \u4f4e\u70ad\u6c34\u5316\u7269\u98df\u3068\u9577\u6642\u9593\u7d76\u98df\u4f75\u7528\u306b\u3088\u308b\u5fc3\u7b4b\u306e\u751f\u7406\u7684FDG\u96c6\u7a4d\u306e\u5b8c\u5168\u306a\u6291\u5236\u306b\u3064\u3044\u3066. \u7b2c56\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a.\uff082016. 11, \u540d\u53e4\u5c4b\uff09
\n44.\u7530\u4e2d\u5b8f\u660e, \u5927\u4e0b\u5b97\u4eae, \u99ac\u8d8a\u5065\u4ecb, \u76f8\u5f15\u771e\u5e78. \u30b9\u30c6\u30f3\u30c8\u30b0\u30e9\u30d5\u30c8\u5185\u633f\u8853\u3092\u65bd\u884c\u3057\u305f\u5c3f\u7ba1\u52d5\u8108\u763b\u306e4\u4f8b. \u7b2c44\u56de\u65e5\u672c\u6551\u6025\u533b\u5b66\u4f1a\u7dcf\u4f1a.\uff082016. 11, \u6771\u4eac\uff09
\n45.\u7530\u4e2d\u5b8f\u660e, \u6d25\u7530\u5b5d\u6cbb, \u5ddd\u53e3\u76f4\u4eba, \u5927\u4e0b\u5b97\u4eae, \u671b\u6708\u8f1d\u4e00. \u80ba\u52d5\u8108\u304a\u3088\u3073\u80ba\u9759\u8108\u304b\u3089\u30b3\u30a4\u30eb\u585e\u6813\u3057\u305f\u80ba\u52d5\u9759\u8108\u5947\u5f62\u306e1\u4f8b. \u7b2c45\u56de\u65e5\u672cIVR\u5b66\u4f1a\u7dcf\u4f1a.\uff082016. 5, \u540d\u53e4\u5c4b\uff09
\n46.\u7530\u4e2d\u5b8f\u660e, \u6d25\u7530\u5b5d\u6cbb, \u671b\u6708\u8f1d\u4e00, \u5927\u4e0b\u5b97\u4eae, \u516b\u6749\u5de7. \u30b3\u30a4\u30eb\u585e\u6813\u8853\u3092\u65bd\u884c\u3057\u305f\u5b64\u7acb\u6027\u8179\u8154\u52d5\u8108\u89e3\u96e2\u306e1\u4f8b. \u7b2c57\u56de\u65e5\u672c\u8108\u7ba1\u5b66\u4f1a\u7dcf\u4f1a.\uff082016. 10, \u5948\u826f\uff09
\n47.\u7530\u4e2d\u5b8f\u660e, \u6d25\u7530\u5b5d\u6cbb, \u671b\u6708\u8f1d\u4e00. \u795e\u7d4c\u7dda\u7dad\u816b\u75c71\u578b\u306b\u5408\u4f75\u3057\u305f\u52d5\u8108\u7834\u88c2\u306b\u5bfe\u3057\u3066\u30b3\u30a4\u30eb\u585e\u6813\u8853\u3092\u65bd\u884c\u3057\u305f1\u4f8b. \u7b2c26\u56de\u65e5\u672c\u6551\u6025\u653e\u5c04\u7dda\u7814\u7a76\u4f1a.\uff082016. 9, \u6771\u4eac\uff09
\n48.\u7530\u908a\u88d5\u8cb4, \u57ce\u6238\u8f1d\u4ec1, \u6a2a\u4e95\u656c\u5f18, \u798f\u5c71\u76f4\u7d00, \u5009\u7530\u8056, \u5c0f\u5ddd\u907c, \u6a2a\u5c71\u3089\u307f, \u57ce\u6238\u502b\u4e4b, \u5bae\u5ddd\u6b63\u7537, \u671b\u6708\u8f1d\u4e00. \u865a\u8840\u6027\u5fc3\u75be\u60a3\u306b\u304a\u3051\u308bSingle-phase CT perfusion imaging\u306e\u6700\u9069\u64ae\u5f71\u6642\u76f8\u306b\u3064\u3044\u3066. \u7b2c26\u56de\u65e5\u672c\u5fc3\u8840\u7ba1\u753b\u50cf\u52d5\u614b\u5b66\u4f1a.\uff082016. 1, \u6771\u4eac\uff09
\n49.\u7530\u908a\u88d5\u8cb4, \u57ce\u6238\u8f1d\u4ec1, \u6a2a\u4e95\u656c\u5f18, \u798f\u5c71\u76f4\u7d00, \u5009\u7530\u8056, \u57ce\u6238\u502b\u4e4b, \u5c0f\u5ddd\u907c, \u4e2d\u6751\u58ee\u5fd7, \u5bae\u5ddd\u6b63\u7537, \u671b\u6708\u8f1d\u4e00. IMR\u3092\u4f75\u7528\u3057\u305f\u9045\u5ef6\u9020\u5f71CT\u306e\u6709\u7528\u6027\u306b\u3064\u3044\u3066. \u7b2c10\u56deSCCT Japan.\uff082016. 9, \u6771\u4eac\uff09
\n50.\u6771\u91ce\u535a, \u9e7f\u5cf6\u6587, \u5ddd\u6761\u6587\u9686, \u7530\u4e2d\u653f\u884c, \u6c60\u6c34\u6681\u5f66, \u4e2d\u7530\u8302, \u4f0a\u7530\u52dd\u5178, \u8c9e\u5fb3\u307f\u3061\u3053, \u795e\u7530\u606d\u5b50, \u5ba4\u91ce\u4e09\u548c\u5b50, \u85e4\u679d\u88d5\u4e4b, \u963f\u90e8\u5145\u4f2f. \u5fc3\u7b4b\u30b7\u30f3\u30c1\u30b0\u30e9\u30d5\u30a3\u30fc\u306b\u304a\u3051\u308b\u6838\u533b\u5b66\u6240\u898b\u3068\u7981\u7159\u671f\u9593\u306e\u95a2\u9023\u306e\u691c\u8a0e. \u7b2c64\u56de\u65e5\u672c\u5fc3\u81d3\u75c5\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a.\uff082016. 9, \u6771\u4eac\uff09
\n51.\u5fb3\u6c38\u4f38\u5b50, \u5fb3\u5897\u660e\u6587, \u53ea\u4fe1\u7f8e\u7d00, \u7d30\u5ddd\u6d69\u5e73, \u6850\u5c71\u90c1\u5b50, \u6e05\u6c34\u8f1d\u5f66, \u9152\u4e95\u4f38\u4e5f, \u83c5\u539f\u656c\u6587, \u5927\u4e80\u771f\u4e00, \u5c0f\u677e\u6b63\u660e, \u7af9\u539f\u548c\u5b8f, \u5bfa\u672c\u5178\u5f18. \u6210\u719f\u56a2\u80de\u6027\u5947\u5f62\u816b\u306e\u60aa\u6027\u8ee2\u5316\u3068\u306e\u9451\u5225\u306b\u82e6\u616e\u3057\u305f\u985e\u5185\u819c\u764c\u306e1\u4f8b. JSAWI2016, 17th Annual Symposium.\uff082016. 9, \u6de1\u8def\uff09
\n52.\u5fb3\u5897\u660e\u6587, \u53ea\u4fe1\u7f8e\u7d00, \u7d30\u5ddd\u6d69\u5e73, \u6e05\u6c34\u8f1d\u5f66, \u9152\u4e95\u4f38\u4e5f, \u83c5\u539f\u656c\u6587, \u6d45\u6728\u7ae0\u5247, \u4e8c\u5bae\u90c1, \u5bfa\u672c\u5178\u5f18. \u539f\u767a\u5de3\u306e\u691c\u7d22\u306bFDG-PET\/CT\u304c\u6709\u7528\u3067\u3042\u3063\u305f\u814e\u76c2\u764c\u306e1\u4f8b. \u7b2c56\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a.\uff082016. 11, \u540d\u53e4\u5c4b\uff09
\n53.\u798f\u5c71\u76f4\u7d00, \u57ce\u6238\u8f1d\u4ec1, \u6a2a\u4e95\u656c\u5f18, \u5c0f\u5ddd\u907c, \u7530\u908a\u88d5\u8cb4, \u57ce\u6238\u502b\u4e4b, \u5009\u7530\u8056, \u671b\u6708\u8f1d\u4e00. \u51a0\u52d5\u8108\u652f\u914d\u704c\u6d41\u57df\u89e3\u6790\u30bd\u30d5\u30c8\u3068Perfusion CT\u3092\u7528\u3044\u305f\u5fc3\u7b4b\u8840\u6d41\u91cf\u306b\u95a2\u3059\u308b\u691c\u8a0e. \u7b2c82\u56de\u5fc3\u81d3\u653e\u5c04\u7dda\u7814\u7a76\u4f1a.\uff082016. 1, \u6771\u4eac\uff09
\n54.\u798f\u5c71\u76f4\u7d00, \u57ce\u6238\u8f1d\u4ec1, \u7530\u908a\u88d5\u8cb4, \u6a2a\u4e95\u656c\u5f18, \u5009\u7530\u8056, \u4e09\u6728\u5747, \u671b\u6708\u8f1d\u4e00. \u5c0f\u5150\u5fc3\u81d3CT\u306b\u304a\u3051\u308bKnowledge-based Iterative Reconstruction\u306e\u6709\u7528\u6027. \u7b2c\uff11\u56deSociety of Advanced Medical Imaging.\uff082016. 7, \u6771\u4eac\uff09
\n55.\u5e73\u585a\u7fa9\u5eb7, \u83ca\u6c60\u6075\u4e00, \u5927\u4e0a\u53f2\u6717, \u4e95\u4e0a\u6b66, \u4e09\u6728\u5747, \u671b\u6708\u8f1d\u4e00. gliosarcoma\u306b\u304a\u3051\u308bPET\u96c6\u7a4d\u306e\u691c\u8a0e. \u7b2c45\u56de\u65e5\u672c\u795e\u7d4c\u653e\u5c04\u7dda\u5b66\u4f1a.\uff082016. 2, \u5c71\u5f62\uff09
\n56.\u5e73\u585a\u7fa9\u5eb7, \u83ca\u6c60\u6075\u4e00, \u5927\u4e0a\u53f2\u6717, \u4e95\u4e0a\u6b66, \u4e09\u6728\u5747, \u671b\u6708\u8f1d\u4e00. PET\/CT\u3068MRI\u3092\u7528\u3044\u305f\u30c6\u30f3\u30c8\u4e0a\u795e\u7d4c\u81a0\u816b\u306e\u60aa\u6027\u5ea6\u8a55\u4fa1. \u7b2c75\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u7dcf\u4f1a.\uff082016. 4, \u6a2a\u6d5c\uff09
\n57.\u6ff1\u672c\u6cf0, \u795e\u5d0e\u535a\u5145, \u9577\u5d0e\u6167, \u897f\u5cf6\u7d00\u5b50, \u671b\u6708\u8f1d\u4e00. \u982d\u9838\u90e8\u6241\u5e73\u4e0a\u76ae\u764c\u306e\u8853\u5f8c\u7167\u5c04. \u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a\u7b2c29\u56de\u5b66\u8853\u5927\u4f1a\uff0e\uff082016. 11, \u4eac\u90fd\uff09
\n58.\u6ff1\u672c\u6cf0, \u974d\u5ca1\u614e\u592a\u90ce, \u6b66\u7530\u82f1\u6a39, \u771f\u934b\u4fca\u6cbb. \u80ba\u764c\u3078\u306e\u5be1\u5206\u5272\u7167\u5c04\u5f8c\u306b\u767a\u751f\u3057\u305f\u653e\u5c04\u7dda\u80ba\u81d3\u708e\u306e\u7d4c\u9a13. \u7b2c54\u56de\u65e5\u672c\u764c\u6cbb\u7642\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff0e\uff082016. 10, \u6a2a\u6d5c\uff09
\n59.\u974d\u5ca1\u614e\u592a\u90ce, \u7247\u5ca1\u6b63\u660e, \u4e0a\u6d25\u5b5d\u592a\u90ce, \u897f\u5ddd\u6566, \u671b\u6708\u8f1d\u4e00. \u5b50\u5bae\u9838\u764c\u653e\u5c04\u7dda\u6cbb\u7642\u75c7\u4f8b\u306b\u304a\u3051\u308bMRI\u3067\u306e\u5897\u6b96\u5f62\u614b\u3068\u4e88\u5f8c. \u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a\u7b2c29\u56de\u5b66\u8853\u5927\u4f1a\uff0e\uff082016. 11, \u4eac\u90fd\uff09
\n<\/a>\u25cf<\/span> \u56fd\u5185\u5b66\u4f1a\uff08\u5730\u65b9\u4f1a\uff09
\n1.\u68b6\u539f\u8aa0, \u6d77\u8001\u539f\u308b\u3044, \u77f3\u5d0e\u793c\u7f8e, \u6751\u7530\u771f\u592e, \u6d66\u5cf6\u96c4\u4ecb, \u677e\u7530\u5065, \u83ca\u6c60\u6075\u4e00. Rosai-Dorfman\u75c5\u306e3\u4f8b.\u3000\u7b2c127\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a.\uff082016. 12, \u5fb3\u5cf6\uff09
\n2.\u5409\u7530\u548c\u6a39, \u4e95\u4e0a\u6b66, \u9ad8\u9580\u653f\u5609, \u77f3\u5ddd\u6d69\u53f2, \u5bae\u672c\u52a0\u5948\u5b50, \u80fd\u7530\u7d17\u4ee3, \u7530\u4ee3\u3089\u307f, \u5ddd\u53e3\u76f4\u4eba, \u68ee\u5343\u5c0b, \u6751\u4e0a\u5fe0\u53f8, \u677e\u6728\u5f18\u91cf, \u77f3\u4e38\u826f\u5e83, \u9ad8\u6a4b\u5fe0\u7ae0, \u767c\u77e5\u5553\u5b50, \u4e09\u6728\u5747. \u74b0\u690e\u9aa8\u6298\u3092\u5951\u6a5f\u306b\u8a3a\u65ad\u3055\u308c\u305fCraniocervical Pneumatization\uff08CCP\uff09\u306e\u4e00\u4f8b. \u7b2c127\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a.\uff082016. 12, \u5fb3\u5cf6\uff09
\n3.\u5409\u7530\u548c\u6a39, \u4e09\u6728\u5747, \u9ad8\u9580\u653f\u5609, \u77f3\u5ddd\u6d69\u53f2, \u5916\u7912\u5343\u667a, \u80fd\u7530\u7d17\u4ee3, \u7530\u4ee3\u3089\u307f, \u5ddd\u53e3\u76f4\u4eba, \u68ee\u5343\u5c0b, \u6751\u4e0a\u5fe0\u53f8, \u9ad8\u6a4b\u5fe0\u7ae0, \u677e\u6728\u5f18\u91cf, \u77f3\u4e38\u826f\u5e83, \u4e95\u4e0a\u6b66. \u80a5\u539a\u6027\u786c\u819c\u708e\u3092\u5408\u4f75\u3057\u305f\u591a\u767a\u8840\u7ba1\u708e\u6027\u8089\u82bd\u816b\u75c7(GPA)\u306e\u4e00\u4f8b. \u7b2c126\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a.\uff082016. 6, \u5e83\u5cf6\uff09
\n4.\u5409\u7530\u548c\u6a39, \u7530\u4e2d\u5b8f\u660e, \u6d25\u7530\u5b5d\u6cbb, \u671b\u6708\u8f1d\u4e00, \u4ed6. \u8179\u8154\u52d5\u8108\u89e3\u96e2\u306b\u5bfe\u3057\u3066\u30b3\u30a4\u30eb\u585e\u6813\u8853\u3092\u65bd\u884c\u3057\u305f1\u4f8b. \u7b2c11\u56de\u611b\u5a9bInterventional Radiology\uff08IVR\uff09\u7814\u7a76\u4f1a.\uff082016. 2, \u677e\u5c71\uff09
\n5.\u5bae\u5185\u7b11\u9e97, \u5bae\u5ddd\u6b63\u7537, \u77f3\u6751\u96bc\u4eba, \u897f\u5c71\u9999\u5b50, \u6a2a\u4e95\u656c\u5f18, \u5c0f\u5ddd\u907c, \u7530\u908a\u88d5\u8cb4, \u798f\u5c71\u76f4\u7d00, \u4e2d\u6751\u58ee\u5fd7, \u57ce\u6238\u502b\u4e4b, \u57ce\u6238\u8f1d\u4ec1, \u5009\u7530\u8056, \u671b\u6708\u8f1d\u4e00. \u5fc3\u81d3\u5c02\u7528\u534a\u5c0e\u4f53SPECT\u88c5\u7f6e\uff1aDNM530c\u3092\u7528\u3044\u305f\u5fc3\u7b4b\u8840\u6d41\u4e88\u5099\u80fd\u306e\u6e2c\u5b9a. \u7b2c35\u56de\u305b\u3068\u3046\u3061\u5fc3\u81d3CT\u2022MR\u52c9\u5f37\u4f1a.\uff082016. 11, \u5e83\u5cf6\uff09
\n6.\u5bae\u5185\u7b11\u9e97, \u5bae\u5ddd\u6b63\u7537, \u77f3\u6751\u96bc\u4eba, \u671b\u6708\u8f1d\u4e00. \u5fc3\u81d3\u5c02\u7528\u534a\u5c0e\u4f53\u88c5\u7f6e\u306b\u3088\u308b\u30c0\u30a4\u30ca\u30df\u30c3\u30af\u53ce\u96c6SPECT\u753b\u50cf\u306e\u691c\u8a0e. \u7b2c33\u56de\u3057\u307e\u306a\u307f\u30ab\u30f3\u30d5\u30a1\u30ec\u30f3\u30b9.\uff082016. 6, \u4eca\u6cbb\uff09
\n7.\u5bae\u672c\u52a0\u5948\u5b50, \u677e\u6728\u5f18\u91cf, \u5409\u7530\u548c\u6a39, \u9ad8\u9580\u653f\u5609, \u77f3\u5ddd\u6d69\u53f2, \u80fd\u7530\u7d17\u4ee3, \u7530\u4ee3\u3089\u307f, \u5ddd\u53e3\u76f4\u4eba, \u68ee\u5343\u5c0b, \u6751\u4e0a\u5fe0\u53f8, \u77f3\u4e38\u826f\u5e83, \u9ad8\u6a4b\u5fe0\u7ae0, \u4e95\u4e0a\u6b66, \u4e09\u6728\u5747. \u5f53\u9662\u306b\u304a\u3051\u308b\u982d\u981a\u90e8\u6241\u5e73\u4e0a\u76ae\u764c\u306b\u5bfe\u3059\u308b\u30bb\u30c4\u30ad\u30b7\u30de\u30d6\u4f75\u7528\u306e\u653e\u5c04\u7dda\u6cbb\u7642\u7d4c\u9a13. \u7b2c127\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a.\uff082016. 12, \u5fb3\u5cf6\uff09
\n8.\u9ad8\u9580\u653f\u5609, \u4e09\u6728\u5747, \u5409\u7530\u548c\u6a39, \u77f3\u5ddd\u6d69\u53f2, \u5916\u7912\u5343\u667a, \u80fd\u7530\u7d17\u4ee3, \u7530\u4ee3\u3089\u307f, \u5ddd\u53e3\u76f4\u4eba, \u68ee\u5343\u5c0b, \u6751\u4e0a\u5fe0\u53f8, \u9ad8\u6a4b\u5fe0\u7ae0, \u677e\u6728\u5f18\u91cf, \u77f3\u4e38\u826f\u5e83, \u4e95\u4e0a\u6b66. \u810a\u67f1\u7ba1\u5185\u9aa8\u8edf\u9aa8\u816b\u306e\u4e00\u4f8b. \u7b2c126\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a.\uff082016. 6, \u5e83\u5cf6\uff09
\n9.\u9ad8\u9580\u653f\u5609, \u5ddd\u53e3\u76f4\u4eba, \u6751\u4e0a\u5fe0\u53f8, \u77f3\u4e38\u826f\u5e83, \u4e95\u4e0a\u6b66, \u4e09\u6728\u5747, \u7530\u4e2d\u5b8f\u660e, \u671b\u6708\u8f1d\u4e00. \u5de8\u5927\u9580\u8108-\u5927\u5faa\u74b0\u30b7\u30e3\u30f3\u30c8\u306b\u5bfe\u3057\u3066\u30b3\u30a4\u30eb\u585e\u6813\u8853\u3092\u65bd\u884c\u3057\u305f\u809d\u6027\u8133\u75c7\u306e1\u4f8b. \u7b2c30\u56de\u4e2d\u56fd\u56db\u56fdIVR\u7814\u7a76\u4f1a.\uff082016. 9, \u5ca1\u5c71\uff09
\n10.\u5c0f\u5ddd\u907c, \u4e2d\u6751\u58ee\u5fd7, \u57ce\u6238\u502b\u4e4b, \u57ce\u6238\u8f1d\u4ec1, \u671b\u6708\u8f1d\u4e00. Feature-tracking CMR\u306b\u3088\u308bMyocardial Strain\u89e3\u6790. \u7b2c34\u56de\u3057\u307e\u306a\u307f\u30ab\u30f3\u30d5\u30a1\u30ec\u30f3\u30b9.\uff082016. 10, \u4eca\u6cbb\uff09
\n11.\u897f\u5cf6\u7d00\u5b50, \u7247\u5ca1\u6b63\u660e, \u6ff1\u672c\u6cf0, \u897f\u5ddd\u6566, \u4e0a\u6d25\u5b5d\u592a\u90ce, \u974d\u5ca1\u614e\u592a\u90ce, \u795e\ufa11\u535a\u5145, \u9577\ufa11\u6167, \u671b\u6708\u8f1d\u4e00. \u98df\u9053\u764c\u5316\u5b66\u653e\u5c04\u7dda\u7642\u6cd5\u5f8c\u306e\u5fc3\u56a2\u6db2\u8caf\u7559. \u7b2c68\u56de\u4e2d\u56fd\u30fb\u56db\u56fd\u653e\u5c04\u7dda\u6cbb\u7642\u61c7\u8a71\u4f1a.\uff082016. 6, \u5e83\u5cf6\uff09
\n12.\u5ddd\u53e3\u76f4\u4eba, \u83ca\u6c60\u9686\u5fb3, \u4e95\u4e0a\u6b66, \u4e09\u6728\u5747, \u4ed6. \u5fc3\u81d3CT\u3092\u7528\u3044\u305f\u51a0\u52d5\u8108\u652f\u914d\u704c\u6d41\u57df\u89e3\u6790\u30bd\u30d5\u30c8\u3068\u30a2\u30f3\u30e2\u30cb\u30a2PET\u306b\u3088\u308b\u865a\u8840\u9818\u57df\u306e\u691c\u8a0e. \u7b2c54\u56de\u611b\u5a9b\u770c\u7acb\u75c5\u9662\u5b66\u4f1a.\uff082016. 11, \u677e\u5c71\uff09
\n13.\u5ddd\u53e3\u76f4\u4eba. \u591a\u767a\u80ba\u52d5\u9759\u8108\u5947\u5f62\u306b\u5bfe\u3057\u3066\u30b3\u30a4\u30eb\u585e\u6813\u8853\u3092\u65bd\u884c\u3057\u305f\uff11\u4f8b. \u7b2c1\u56de\u56db\u56fdIVR\u30bb\u30df\u30ca\u30fc.\uff082016. 1, \u65b0\u5c45\u6d5c\uff09
\n14.\u5ddd\u53e3\u76f4\u4eba. \u813e\u52d5\u8108\u7624\u7834\u88c2\u306e\uff11\u4f8b. \u7b2c2\u56de\u56db\u56fdIVR\u30bb\u30df\u30ca\u30fc.\uff082016. 10, \u65b0\u5c45\u6d5c\uff09
\n\u5927\u4e0b\u5b97\u4eae, \u7530\u4e2d\u5b8f\u660e, \u671b\u6708\u8f1d\u4e00, \u6709\u5149\u82f1\u6cbb. \u7d4c\u76ae\u7684\u5185\u8996\u93e1\u7684\u80c3\u763b\u9020\u8a2d\u8853\u306b\u4f34\u3046\u4e0a\u8179\u58c1\u52d5\u8108\u640d\u50b7\u306e1\u4f8b. \u7b2c30\u56de\u4e2d\u56fd\u56db\u56fdIVR\u7814\u7a76\u4f1a.\uff082016. 9, \u5ca1\u5c71\uff09
\n15.\u53ea\u4fe1\u7f8e\u7d00, \u5fb3\u5897\u660e\u6587, \u7d30\u5ddd\u6d69\u5e73, \u5fb3\u6c38\u4f38\u5b50, \u6850\u5c71\u90c1\u5b50, \u6e05\u6c34\u8f1d\u5f66, \u9152\u4e95\u4f38\u4e5f, \u83c5\u539f\u656c\u6587, \u5409\u7530\u529f, \u9752\u5100\u5065\u4e8c\u90ce, \u5bfa\u672c\u5178\u5f18. \u8178\u9593\u819c\u306b\u767a\u751f\u3057\u305f\u9aa8\u5916\u6027\u5f62\u8cea\u7d30\u80de\u816b\u306e1\u4f8b. \u7b2c127\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a.\uff082016. 12, \u5fb3\u5cf6\uff09
\n16.\u4e2d\u5cf6\u76f4\u7f8e, \u4e95\u4e0a\u7950\u99ac, \u5ca9\u6751\u5353\u660e, \u7af9\u53e3\u5d07, \u798f\u4e95\u8061. \u5f53\u9662\u306b\u304a\u3051\u308b\u76f4\u8178\u764c\u8853\u524d\u5316\u5b66\u653e\u5c04\u7dda\u7642\u6cd5\u65bd\u884c\u4f8b\u306e\u6cbb\u7642\u6210\u7e3e. \u7b2c126\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a.\uff082016. 12, \u5fb3\u5cf6\uff09
\n17.\u5fb3\u6c38\u4f38\u5b50, \u5fb3\u5897\u660e\u6587, \u53ea\u4fe1\u7f8e\u7d00, \u7d30\u5ddd\u6d69\u5e73, \u6850\u5c71\u90c1\u5b50, \u6e05\u6c34\u8f1d\u5f66, \u9152\u4e95\u4f38\u4e5f, \u83c5\u539f\u656c\u6587, \u5927\u4e80\u771f\u4e00, \u5c0f\u677e\u6b63\u660e, \u7af9\u539f\u548c\u5b8f, \u5bfa\u672c\u5178\u5f18. \u5375\u5de3serous borderline tumor-micropapillary variant\u306e1\u4f8b. \u7b2c126\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a.\uff082016. 6, \u5e83\u5cf6\uff09
\n18.\u5fb3\u5897\u660e\u6587, \u53ea\u4fe1\u7f8e\u7d00, \u7d30\u5ddd\u6d69\u5e73, \u5fb3\u6c38\u4f38\u5b50, \u6850\u5c71\u90c1\u5b50, \u6e05\u6c34\u8f1d\u5f66, \u9152\u4e95\u4f38\u4e5f, \u83c5\u539f\u656c\u6587, \u5927\u7530\u8015\u53f8, \u5409\u7530\u529f, \u897f\u6751\u7406\u6075\u5b50, \u6a2a\u7530\u667a\u884c, \u4e0a\u7532\u5eb7\u4e8c. \u81b5\u539f\u767a\u60aa\u6027\u30ea\u30f3\u30d1\u816b\u306e1\u4f8b. \u7b2c126\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a.\uff082016. 6, \u5e83\u5cf6\uff09
\n19.\u974d\u5ca1\u614e\u592a\u90ce, \u7530\u4e2d\u5b8f\u660e, \u6b66\u7530\u82f1\u6a39, \u6ff1\u672c\u6cf0, \u771f\u934b\u4fca\u6cbb, \u4ed6. \u653e\u5c04\u7dda\u6cbb\u7642\u5f8c\u306e\u809d\u7d30\u80de\u764c\u5de6\u8178\u9aa8\u8ee2\u79fb\u306b\u5bfe\u3057\u3066\u75c7\u72b6\u7de9\u548c\u76ee\u7684\u306b\u585e\u6813\u8853\u3092\u65bd\u884c\u3057\u305f\uff11\u4f8b. \u7b2c11\u56de\u611b\u5a9bInterventional Radiology\uff08IVR\uff09\u7814\u7a76\u4f1a.\uff082016. 2, \u611b\u5a9b\uff09
\n20.\u974d\u5ca1\u614e\u592a\u90ce, \u7247\u5ca1\u6b63\u660e, \u4e0a\u6d25\u5b5d\u592a\u90ce, \u897f\u5ddd\u6566, \u671b\u6708\u8f1d\u4e00. \u5b50\u5bae\u9838\u764c\u306b\u5bfe\u3059\u308b\u6839\u6cbb\u7684\u653e\u5c04\u7dda\u6cbb\u7642\u75c7\u4f8b\u306e\u518d\u767a\u5f62\u5f0f\u306e\u691c\u8a0e. \u7b2c126\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u4e2d\u56db\u56fd\u5730\u65b9\u4f1a\uff0e\uff082016. 6, \u5e83\u5cf6\uff09
\n21.\u974d\u5ca1\u614e\u592a\u90ce, \u7247\u5ca1\u6b63\u660e, \u4e0a\u6d25\u5b5d\u592a\u90ce, \u897f\u5ddd\u6566, \u671b\u6708\u8f1d\u4e00. \u4e73\u764c\u8133\u8ee2\u79fb\u75c7\u4f8b\u306e\u653e\u5c04\u7dda\u6cbb\u7642\u6210\u7e3e\u306e\u691c\u8a0e. \u7b2c127\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a\uff0e\uff082016. 12, \u5fb3\u5cf6\uff09
\n<\/a>\u25a0<\/span> \u8b1b\u6f14<\/strong>
\n1.Miyagawa M. Continuing Education Session: Detection and Assessment of Cardiac Sarcoidosis by FDG-PET. \u201cPatient Preparation for FDG-PET.\u201d Seminar of Nuclear Medicine and Molecular Imaging (SNMMI) 63th Annual Meeting. (2016. 6, San Diego, USA)
\n2.\u4e95\u4e0a\u6b66. \u8033\u9f3b\u54bd\u5589\u79d1\u9818\u57df\u306b\u304a\u3051\u308bPET-CT\u306e\u6709\u7528\u6027\u3068\u9650\u754c. \u677e\u5c71\u8033\u9f3b\u79d1\u533b\uff0e\uff082016. 11, \u677e\u5c71\uff09
\n3.\u4e95\u4e0a\u6b66. \u814e\u306e\u753b\u50cf\u8a3a\u65ad. \u677e\u5c71\u653e\u5c04\u7dda\u79d1\u533b\u4f1a\uff0e\uff082016. 2, \u677e\u5c71\uff09
\n4.\u68b6\u539f\u8aa0, PET\u306e\u8fd1\u5e74\u306e\u9032\u6b69\u3068\u5c06\u6765\u5c55\u671b \u2014\u9ad8\u901f\u5316,\u9ad8\u89e3\u50cf\u5ea6\u5316,\u65b0\u305f\u306a\u6838\u7a2e\u3068\u5fdc\u7528\u2014. \u677e\u5c71\u8d64\u5341\u5b57\u75c5\u9662\u3000\u7b2c33\u56de\u6d88\u5316\u5668\u5408\u540c\u30ab\u30f3\u30d5\u30a1\u30ec\u30f3\u30b9.\uff082016. 3, \u677e\u5c71\uff09
\n5.\u5bae\u5ddd\u6b63\u7537. PET\u7814\u4fee\u30bb\u30df\u30ca\u30fc\u533b\u5e2b\u30fb\u6b6f\u79d1\u533b\u5e2b\u30b3\u30fc\u30b9 \u8b1b\u6f14\uff1a\u81e8\u5e8a\u7de82. \u5fc3\u7b4bViability, \u5fc3\u7b4b\u708e\u75c7. \u7b2c16\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u6625\u5b63\u5927\u4f1a.\uff082016. 4, \u5927\u962a\uff09
\n6.\u5bae\u5ddd\u6b63\u7537. \u6838\u533b\u5b66\u57fa\u790e\u30bb\u30df\u30ca\u30fc\u521d\u5fc3\u8005\u30fb\u5352\u5f8c\u7814\u4fee\u533b\u30b3\u30fc\u30b9 \u8b1b\u6f14\uff1a\u5fc3\u81d3\u6838\u533b\u5b66\u306e\u57fa\u790e\u3068\u81e8\u5e8a. \u7b2c16\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u6625\u5b63\u5927\u4f1a.\uff082016.4, \u5927\u962a\uff09
\n7.\u5bae\u5ddd\u6b63\u7537. \u6838\u533b\u5b66\u5c02\u9580\u533b\u6559\u80b2\u30bb\u30df\u30ca\u30fc\u5c02\u9580\u533b\u53d7\u9a13\u8005\u30b3\u30fc\u30b9 \u8b1b\u6f14\uff1a\u5fc3\u81d3\u6838\u533b\u5b66\uff08\u57fa\u790e\u3068\u81e8\u5e8a\uff09. \u7b2c16\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u6625\u5b63\u5927\u4f1a.\uff082016. 4, \u5927\u962a\uff09
\n8.\u5bae\u5ddd\u6b63\u7537. \u6559\u80b2\u8b1b\u6f14 \u201cAppropriate Procedures for Myocardial Perfusion SPECT\u201d\u300c\u5fc3\u7b4b\u8840\u6d41SPECT\u306e\u691c\u67fb\u6cd5\u300d. \u7b2c75\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u7dcf\u4f1a.\uff082016. 4, \u6a2a\u6d5c\uff09
\n9.\u5bae\u5ddd\u6b63\u7537. \u6559\u80b2\u8b1b\u6f14 \u5fc3\u7b4b\u8840\u6d41\u4e88\u5099\u80fd\u6e2c\u5b9a\u3092\u3081\u3056\u3057\u305f\u30c0\u30a4\u30ca\u30df\u30c3\u30af\u534a\u5c0e\u4f53SPECT\u64ae\u5f71\u6cd5. \u7b2c56\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a.\uff082016. 11, \u540d\u53e4\u5c4b\uff09
\n10.\u5bae\u5ddd\u6b63\u7537. \u7279\u5225\u8b1b\u6f14 \u5fc3\u30b5\u30eb\u30b3\u30a4\u30c9\u30fc\u30b7\u30b9\u306b\u304a\u3051\u308bFDG-PET\u306e\u6709\u7528\u6027. \u7b2c8\u56deFunctional Imaging Update.\uff082016. 11, \u9ce5\u53d6\uff09
\n11.\u4e09\u6728\u5747. CNS\u611f\u67d3\u75c7\u306e\u753b\u50cf\u8a3a\u65ad. \u677e\u5c71\u653e\u5c04\u7dda\u79d1\u533b\u4f1a\uff0e\uff082016. 6, \u677e\u5c71\uff09
\n12.\u4e09\u6728\u5747. \u7523\u5a66\u4eba\u79d1\u306e\u753b\u50cf\u8a3a\u65ad MRI update\u3092\u4e2d\u5fc3\u306b. \u677e\u5c71\u7523\u5a66\u4eba\u79d1\u533b\u4f1a.\uff082016. 1, \u677e\u5c71\uff09
\n13.\u4e09\u6728\u5747. \u795e\u7d4c\u653e\u5c04\u7dda\u8a3a\u65ad\u306e\u30a8\u30c3\u30bb\u30f3\u30b9. \u5e83\u5cf6\u30e1\u30c7\u30a3\u30ab\u30eb\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\u30bb\u30df\u30ca\u30fc.\uff082016. 7, \u5e83\u5cf6\uff09
\n14.\u5c71\u672c\u5c1a\u5e78. Radiation emergency medicine in Japan and the act of NSRA. \u5e83\u5cf6\u5927\u5b66\u30d5\u30a7\u30cb\u30c3\u30af\u30b9\u30d7\u30ed\u30b0\u30e9\u30e0.\uff082016. 1, \u5e83\u5cf6\uff09
\n15.\u5c71\u672c\u5c1a\u5e78. \u539f\u5b50\u529b\u707d\u5bb3\u6642\u306e\u5165\u9662\u60a3\u8005\u907f\u96e3. \u67cf\u5d0e\u5208\u7fbd\u5730\u533a\u8b1b\u6f14\u4f1a\u5b9f\u52d9\u30bb\u30df\u30ca\u30fc.\uff082016. 1, \u67cf\u5d0e\uff09
\n16.\u5c71\u672c\u5c1a\u5e78. \u5b89\u5b9a\u30e8\u30a6\u7d20\u5264\u306e\u7dca\u6025\u914d\u5e03\uff0e\uff082016. 8, \u67cf\u5d0e\uff09
\n17.\u5c71\u672c\u5c1a\u5e78. \u5b89\u5b9a\u30e8\u30a6\u7d20\u5264\u306e\u914d\u5e03\u65b9\u6cd5\u3068\u305d\u306e\u5bfe\u5fdc. \u9752\u68ee\u770c\u5b89\u5b9a\u30e8\u30a6\u7d20\u5264\u7814\u4fee\u4f1a.\uff082016. 10, \u3080\u3064\uff09
\n18.\u5c71\u672c\u5c1a\u5e78. \u5b89\u5b9a\u30e8\u30a6\u7d20\u5264\u306e\u914d\u5e03\u65b9\u6cd5\u3068\u305d\u306e\u5bfe\u5fdc. \u9752\u68ee\u770c\u5b89\u5b9a\u30e8\u30a6\u7d20\u5264\u7814\u4fee\u4f1a.\uff082016. 9, \u6771\u901a\uff09
\n19.\u5c71\u672c\u5c1a\u5e78. \u5b89\u5b9a\u30e8\u30a6\u7d20\u5264\u306e\u670d\u7528\u3068\u52b9\u679c. \u5cf6\u6839\u770c\u5b89\u5b9a\u30e8\u30a6\u7d20\u5264\u7814\u4fee\u4f1a.\uff082016. 7, \u677e\u6c5f\uff09
\n20.\u5c71\u672c\u5c1a\u5e78. \u5b89\u5b9a\u30e8\u30a6\u7d20\u5264\u306e\u670d\u7528\u3068\u52b9\u679c. \u5cf6\u6839\u770c\u5b89\u5b9a\u30e8\u30a6\u7d20\u5264\u7814\u4fee\u4f1a.\uff082016. 8, \u677e\u6c5f\uff09
\n21.\u5c71\u672c\u5c1a\u5e78. \u5b89\u5b9a\u30e8\u30a6\u7d20\u5264\u306e\u670d\u7528\u3068\u52b9\u679c. \u5317\u6d77\u9053\u5b89\u5b9a\u30e8\u30a6\u7d20\u5264\u7814\u4fee\u4f1a.\uff082016. 5, \u5171\u548c\u753a\uff09
\n22.\u5c71\u672c\u5c1a\u5e78. \u7dca\u6025\u88ab\u3070\u304f\u533b\u7642\u306e\u57fa\u790e. \u5cf6\u6839\u5730\u533a\u8b1b\u6f14\u4f1a\u5b9f\u52d9\u30bb\u30df\u30ca\u30fc.\uff082016. 1, \u677e\u6c5f\uff09
\n23.\u5c71\u672c\u5c1a\u5e78. \u539f\u5b50\u529b\u707d\u5bb3\u533b\u7642\u306b\u95a2\u3059\u308b\u56fd\u306e\u52d5\u5411\u306b\u3064\u3044\u3066. \u611b\u5a9b\u770c\u30b3\u30a2\u30e1\u30f3\u30d0\u30fc\u4f1a\u8b70.\uff082016. 2, \u677e\u5c71\uff09
\n24.\u5c71\u672c\u5c1a\u5e78. \u539f\u5b50\u529b\u707d\u5bb3\u533b\u7642\u4f53\u5236\u306b\u3064\u3044\u3066. \u9577\u5d0e\u770c\u539f\u5b50\u529b\u707d\u5bb3\u533b\u7642\u7814\u4fee\u4f1a.\uff082016. 9, \u4f50\u4e16\u4fdd\uff09
\n25.\u5c71\u672c\u5c1a\u5e78. \u539f\u5b50\u529b\u707d\u5bb3\u6642\u306e\u5b89\u5b9a\u30e8\u30a6\u7d20\u5264\u306e\u52b9\u679c\u7b49\u306b\u3064\u3044\u3066. \u9759\u5ca1\u770c\u5b89\u5b9a\u30e8\u30a6\u7d20\u5264\u7814\u4fee\u4f1a.\uff082016. 3, \u5fa1\u524d\u5d0e\uff09
\n26.\u5c71\u672c\u5c1a\u5e78. \u539f\u5b50\u529b\u707d\u5bb3\u6642\u306e\u533b\u7642\u4f53\u5236. \u6ecb\u8cc0\u770c\u88ab\u3070\u304f\u533b\u7642\u30cd\u30c3\u30c8\u30ef\u30fc\u30af\u7814\u4fee\u4f1a.\uff082016. 3, \u702c\u7530\uff09
\n27.\u5c71\u672c\u5c1a\u5e78. \u539f\u5b50\u529b\u707d\u5bb3\u5bfe\u7b56\u6307\u91dd\u306e\u6539\u6b63\u306b\u3064\u3044\u3066. \u6cca\u5730\u533a\u8b1b\u6f14\u4f1a\u30fb\u5b9f\u52d9\u30bb\u30df\u30ca\u30fc.\uff082016. 10, \u672d\u5e4c\uff09
\n28.\u5c71\u672c\u5c1a\u5e78. \u539f\u5b50\u529b\u707d\u5bb3\u5bfe\u7b56\u6307\u91dd\u306e\u6539\u6b63\u306b\u3064\u3044\u3066. \u516d\u30f6\u6240\u5730\u533a\u8b1b\u6f14\u4f1a\u30fb\u5b9f\u52d9\u30bb\u30df\u30ca\u30fc.\uff082016. 11, \u516b\u6238\uff09
\n29.\u5c71\u672c\u5c1a\u5e78. \u88ab\u3070\u304f\u533b\u7642\u306e\u5b9f\u969b \u767a\u707d\u73fe\u5834\u304b\u3089\u533b\u7642\u5bfe\u5fdc\u307e\u3067. \u611b\u5a9b\u770c\u30b3\u30a2\u30e1\u30f3\u30d0\u30fc\u4f1a\u8b70.\uff082016. 7, \u677e\u5c71\uff09
\n30.\u5c71\u672c\u5c1a\u5e78. \u75c5\u9662\u306b\u304a\u3051\u308b\u6c5a\u67d3\u50b7\u75c5\u8005\u306e\u53d7\u5165. \u5927\u9593\u75c5\u9662\u7814\u4fee\u4f1a.\uff082016. 7, \u5927\u9593\uff09
\n31.\u5c71\u672c\u5c1a\u5e78. \u653e\u5c04\u7dda\u304a\u3088\u3073\u539f\u5b50\u529b\u707d\u5bb3\u533b\u7642\u306e\u7dcf\u8ad6. \u65b0\u6f5f\u5927\u5b66\u539f\u5b50\u529b\u707d\u5bb3\u5f93\u4e8b\u8005\u7814\u4fee\u4f1a.\uff082016. 12, \u4eac\u90fd\uff09
\n32.\u5c71\u672c\u5c1a\u5e78. \u653e\u5c04\u7dda\u306e\u304a\u306f\u306a\u3057. \u8eab\u306e\u56de\u308a\u306e\u653e\u5c04\u7dda\u6e2c\u5b9a\u4f53\u9a13\u6559\u5ba4.\uff082016. 7, \u65b0\u5c45\u6d5c\uff09
\n33.\u57ce\u6238\u8f1d\u4ec1. ATP\u8ca0\u8377\u5fc3\u7b4bDynamic Perfusion CT\u89e3\u6790\u306b\u3064\u3044\u3066. \u7b2c10\u56deSCCT\u7814\u7a76\u4f1a.\uff082016. 9, \u54c1\u5ddd\uff09
\n34.\u57ce\u6238\u8f1d\u4ec1. CT\/MRI\u306b\u3088\u308b\u5fc3\u7b4bPerfusion Imaging. Bayer Abend 2016.\uff082016. 4, \u6a2a\u6d5c\uff09
\n35.\u57ce\u6238\u8f1d\u4ec1. Perfusion CT up to date: MBF\/CT-QFR. \u7b2c2\u56dePCI Optimization by Physiology and Imaging.\uff082016. 9, \u5c90\u961c\uff09
\n36.\u57ce\u6238\u8f1d\u4ec1. The Role of Multimodality Imaging in the Management of Cardiac Disease. \u7b2c75\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u7dcf\u4f1a.\uff082016. 4, \u6a2a\u6d5c\uff09
\n37.\u57ce\u6238\u8f1d\u4ec1. VINCENT\u304c\u5207\u308a\u62d3\u304f3D\/4D\u89e3\u6790\u306e\u5c06\u6765\u5c55\u671b\u301c\u5faa\u74b0\u5668\u9818\u57df\u3092\u4e2d\u5fc3\u306b\u301c. FUJIFILM MEDIAL SEMINAR 2016.\uff082016. 7, \u677e\u5c71\uff09
\n38.\u57ce\u6238\u8f1d\u4ec1. VINCENT\u304c\u5207\u308a\u62d3\u304f\u5fc3\u7b4bPerfusion CT\u306e\u65b0\u305f\u306a\u6d3b\u7528. \u7b2c80\u56de\u65e5\u672c\u5faa\u74b0\u5668\u5b66\u4f1a.\uff082016. 3, \u4ed9\u53f0\uff09
\n39.\u57ce\u6238\u8f1d\u4ec1. \u3053\u308c\u304b\u3089\u306e\u5faa\u74b0\u5668\u8a3a\u7642\u306b\u304a\u3051\u308bPerfusion CT\u306e\u5f79\u5272. \u7b2c17\u56de\u660e\u65e5\u306eCardiology\u3092\u8003\u3048\u308b\u4f1a.\uff082016. 8, \u535a\u591a\uff09
\n40.\u57ce\u6238\u8f1d\u4ec1. \u51a0\u52d5\u8108CT\u3092\u6cbb\u7642\u6226\u7565\u306b\u6d3b\u304b\u3059\u305f\u3081\u306b\u3067\u304d\u308b\u3053\u3068\u3001\u77e5\u3063\u3066\u304a\u304f\u3079\u304d\u3053\u3068. START 2016 PCI Live demonstration with Slender Club Japan.\uff082016. 5, \u897f\u6761\uff09
\n41.\u57ce\u6238\u8f1d\u4ec1. \u5faa\u74b0\u5668\u753b\u50cf\u8a3a\u65ad\u306e\u73fe\u72b6\u3068\u5c06\u6765\u5c55\u671b~CT, MRI\u3092\u4e2d\u5fc3\u306b~. Radiology Forum.\uff082016. 9, \u5c71\u68a8\uff09
\n42.\u57ce\u6238\u8f1d\u4ec1. \u5fc3\u7b4bPerfusion CT\u3092\u81e8\u5e8a\u306b\u6d3b\u304b\u3059. \u7b2c21\u56de\u672d\u5e4cHeart Imaging Club.\uff082016. 5, \u672d\u5e4c\uff09
\n43.\u57ce\u6238\u8f1d\u4ec1. \u5fc3\u7b4b\u865a\u8840\u8a3a\u65ad\u306b\u304a\u3051\u308bPerfusion CT\u306e\u6d3b\u7528\u301c\u73fe\u72b6\u3068\u5c06\u6765\u5c55\u671b\u301c. \u4e45\u7559\u7c73\u30a4\u30f3\u30bf\u30fc\u30d9\u30f3\u30b7\u30e7\u30f3\u30bb\u30df\u30ca\u30fc.\uff082016. 5, \u4e45\u7559\u7c73\uff09
\n44.\u57ce\u6238\u8f1d\u4ec1. \u5fc3\u81d3CT\u2014\u7dcf\u8ad6\u2014. \u7b2c52\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u79cb\u5b63\u81e8\u5e8a\u5927\u4f1a.\uff082016. 9, \u65b0\u5bbf\uff09
\n45.\u57ce\u6238\u8f1d\u4ec1. \u5fc3\u81d3CT\u301cPerfusion CT\u3092\u4e2d\u5fc3\u306b. \u7b2c33\u56de\u5317\u6d77\u9053\u5fc3\u81d3\u6838\u533b\u5b66\u7814\u7a76\u4f1a.\uff082016. 2, \u672d\u5e4c\uff09
\n46.\u57ce\u6238\u8f1d\u4ec1. \u5fc3\u81d3CT\u306e\u6700\u65b0\u52d5\u5411\u3068\u5c06\u6765\u5c55\u671b. \u5e73\u621027\u5e74\u5ea6\u611b\u5a9b\u770c\u8a3a\u7642\u653e\u5c04\u7dda\u6280\u5e2b\u4f1a.\uff082016. 3, \u897f\u6761\uff09
\n47.\u57ce\u6238\u8f1d\u4ec1. \u5fc3\u81d3CT\u306e\u6b21\u306a\u308b\u76ee\u6a19~\u30d7\u30e9\u30fc\u30af\u8a55\u4fa1\u3001FFR-CT\u3001Perfusion CT. ATIS Expert Conference.\uff082016. 10, \u535a\u591a\uff09
\n48.\u57ce\u6238\u502b\u4e4b. \u300ePerfusion MRI\u300f \u7b2c48\u56de\u5fc3\u81d3\u6838\u533b\u5b66\u8ac7\u8a71\u4f1a.\uff082016. 1, \u6771\u4eac\uff09
\n49.\u57ce\u6238\u502b\u4e4b. \u300e\u5fc3\u81d3MRI\u306e\u73fe\u72b6\u3068\u672a\u6765\u300f \u5009\u6577\u4e2d\u592eRadiology Now.\uff082016. 3, \u5ca1\u5c71\uff09
\n50.\u57ce\u6238\u502b\u4e4b. \u300e\u80a5\u5927\u578b\u5fc3\u7b4b\u75c7\u306b\u304a\u3051\u308b\u5fc3\u81d3MRI\u306e\u5f79\u5272\u300f\u5fc3\u7b4b\u75c72016.\uff082016. 5, \u9577\u91ce\uff09
\n51.\u795e\ufa11\u535a\u5145. \u6559\u80b2\u30bb\u30df\u30ca\u30fc \u653e\u5c04\u7dda\u816b\u760d\u5b66. \u7b2c127\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u4e2d\u56fd\u30fb\u56db\u56fd\u5730\u65b9\u4f1a.\uff082016. 12, \u5fb3\u5cf6\uff09
\n52.\u83c5\u539f\u656c\u6587. \u30e2\u30fc\u30cb\u30f3\u30b0\u30bb\u30df\u30ca\u30fc2 \u4e73\u764c\u8a3a\u7642\u306b\u304a\u3051\u308bPET\/CT\u306e\u6709\u7528\u6027\u3068\u30d4\u30c3\u30c8\u30d5\u30a9\u30fc\u30eb. \u7b2c13\u56de\u65e5\u672c\u4e73\u764c\u5b66\u4f1a\u4e2d\u56fd\u56db\u56fd\u5730\u65b9\u4f1a.\uff082016. 10, \u677e\u5c71\uff09
\n53.\u6e05\u6c34\u8f1d\u5f66. \u6559\u80b2\u30bb\u30df\u30ca\u30fc \u30de\u30f3\u30e2\u30b0\u30e9\u30d5\u30a3\u77f3\u7070\u5316\u75c5\u5909. \u7b2c13\u56de\u65e5\u672c\u4e73\u764c\u5b66\u4f1a\u4e2d\u56fd\u56db\u56fd\u5730\u65b9\u4f1a.\uff082016. 10, \u677e\u5c71\uff09
\n54.\u897f\u5ddd\u6566. \u982d\u9838\u90e8\u764c\u306eIMRT\u306b\u3064\u3044\u3066. \u677e\u5c71\u5e02\u653e\u5c04\u7dda\u79d1\u533b\u4f1a.\uff082016. 8, \u677e\u5c71\uff09
\n55.\u5ddd\u53e3\u76f4\u4eba. \u30a2\u30f3\u30e2\u30cb\u30a2PET\u3092\u81e8\u5e8a\u306b\u6d3b\u304b\u3059. \u7b2c22\u56de\u5fc3\u81d3\u6838\u533b\u5b66\u61c7\u61c7\u8a71\u4f1a.\uff082016. 10, \u90e1\u5c71\uff09
\n56.\u5009\u7530\u8056. SOMATOM Force\u306e\u521d\u671f\u7d4c\u9a13. SIEMENS\u30e6\u30fc\u30b6\u30fc\u30df\u30fc\u30c6\u30a3\u30f3\u30b0.\uff082016. 9, \u677e\u5c71\uff09
\n57.\u5009\u7530\u8056. \u5fc3\u81d3CT\u306e\u6a5f\u80fd\u30a4\u30e1\u30fc\u30b8\u30f3\u30b0\uff1aCTA-FFR\u306b\u3064\u3044\u3066. \u7b2c10\u56deSCCT\u7814\u7a76\u4f1a \u6559\u80b2\u30bb\u30c3\u30b7\u30e7\u30f3.\uff082016. 9, \u6771\u4eac\uff09
\n58.\u5009\u7530\u8056. \u5fc3\u81d3\u8840\u7ba13\u6b21\u5143\u30e2\u30c7\u30eb\u6587\u732e\u30ec\u30d3\u30e5\u30fc \u30d4\u30c3\u30af\u30a2\u30c3\u30d7\u6587\u732e\u3068\u307e\u3068\u3081. \u7b2c6\u56de\u65e5\u672c\u5fc3\u81d3\u8840\u7ba13\u6b21\u5143\u30e2\u30c7\u30eb\u7814\u7a76\u4f1a\u30bb\u30df\u30ca\u30fc.\uff082016. 8, \u5927\u962a\uff09
\n59.\u5009\u7530\u8056. \u5fc3\u81d3\u8840\u7ba13\u6b21\u5143\u30e2\u30c7\u30eb\u6587\u732e\u30ec\u30d3\u30e5\u30fc. \u7b2c3\u56de\u65e5\u672c\u5fc3\u81d3\u8840\u7ba13\u6b21\u5143\u30e2\u30c7\u30eb\u7814\u7a76\u4f1a\u30bb\u30df\u30ca\u30fc.\uff082016. 2, \u5927\u962a\uff09
\n60.\u5009\u7530\u8056. \u5fc3\u81d3\u8840\u7ba13\u6b21\u5143\u30e2\u30c7\u30eb\u6587\u732e\u30ec\u30d3\u30e5\u30fc. \u7b2c4\u56de\u65e5\u672c\u5fc3\u81d3\u8840\u7ba13\u6b21\u5143\u30e2\u30c7\u30eb\u7814\u7a76\u4f1a\u30bb\u30df\u30ca\u30fc.\uff082016. 4, \u5927\u962a\uff09
\n61.\u5009\u7530\u8056. \u5fc3\u81d3\u8840\u7ba13\u6b21\u5143\u30e2\u30c7\u30eb\u6587\u732e\u30ec\u30d3\u30e5\u30fc. \u7b2c5\u56de\u65e5\u672c\u5fc3\u81d3\u8840\u7ba13\u6b21\u5143\u30e2\u30c7\u30eb\u7814\u7a76\u4f1a\u30bb\u30df\u30ca\u30fc.\uff082016. 6, \u5927\u962a\uff09
\n62.\u5009\u7530\u8056. \u5fc3\u81d3\u8840\u7ba13\u6b21\u5143\u30e2\u30c7\u30eb\u6587\u732e\u30ec\u30d3\u30e5\u30fc. \u7b2c7\u56de\u65e5\u672c\u5fc3\u81d3\u8840\u7ba13\u6b21\u5143\u30e2\u30c7\u30eb\u7814\u7a76\u4f1a\u30bb\u30df\u30ca\u30fc.\uff082016. 12, \u5927\u962a\uff09
\n63.\u5009\u7530\u8056. \u5f3e\u6027\u7d20\u6750\u306e\u5c0f\u5150\u5fc3\u81d33D\u30e2\u30c7\u30eb\u4f5c\u6210\u306e\u7d4c\u9a13. \u7b2c6\u56de\u65e5\u672c\u5fc3\u81d3\u8840\u7ba13\u6b21\u5143\u30e2\u30c7\u30eb\u7814\u7a76\u4f1a\u30bb\u30df\u30ca\u30fc.\uff082016. 8, \u5927\u962a\uff09
\n64.\u5009\u7530\u8056. \u5317\u7c73\u653e\u5c04\u7dda\u5b66\u4f1a\uff08RSNA2016\uff09\u306e\u5b66\u4f1a\u5831\u544a\uff083D\u30e2\u30c7\u30eb\u306b\u95a2\u3059\u308b\uff09. \u7b2c7\u56de\u65e5\u672c\u5fc3\u81d3\u8840\u7ba13\u6b21\u5143\u30e2\u30c7\u30eb\u7814\u7a76\u4f1a\u30bb\u30df\u30ca\u30fc.\uff082016. 12, \u5927\u962a\uff09
\n65.\u53ea\u4fe1\u7f8e\u7d00. \u7279\u5225\u4f01\u753b PET\u75c7\u4f8b\u691c\u8a0e\u4f1a \u9670\u7ff3\u793c\u8b83\uff1aPET\u3067\u3069\u3053\u307e\u3067\u8feb\u308c\u308b\u304b\uff1f-PET\u75c7\u4f8b\u691c\u8a0e\u4f1a-. \u7b2c56\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a.\uff082016. 11, \u540d\u53e4\u5c4b\uff09
\n66.\u4e2d\u6751\u58ee\u5fd7. Compressed sensing\u304c\u5207\u308a\u958b\u304fCMR\u306e\u672a\u6765. \u7b2c44\u56de\u65e5\u672c\u78c1\u6c17\u5171\u9cf4\u533b\u5b66\u4f1a\u5927\u4f1a\u30e9\u30f3\u30c1\u30e7\u30f3\u30bb\u30df\u30ca\u30fc.\uff082016. 9, \u5927\u5bae\uff09
\n67.\u4e2d\u6751\u58ee\u5fd7. \u30a8\u30ad\u30b9\u30d1\u30fc\u30c8\u306e\u305f\u3081\u306e\u6700\u65b0MRI\u6280\u8853\u300cFeature Tracking\u300d SCMR Japan WG Seminar 2016.\uff082016. 7, \u6771\u4eac\uff09
\n68.\u4e2d\u6751\u58ee\u5fd7. Clinical usability of compressed sensing whole-heart coronary MRA.\uff082016. 5, Matsuyama, Japan\uff09
\n69.\u4e2d\u5cf6\u76f4\u7f8e. \u6700\u8fd1\u306e\u9ad8\u7cbe\u5ea6\u653e\u5c04\u7dda\u6cbb\u7642\u5f37\u5ea6\u5909\u8abf\u653e\u5c04\u7dda\u6cbb\u7642\uff08IMRT\uff09\u306e\u5c0e\u5165\u3068\u305d\u306e\u9069\u5fdc\u306b\u3064\u3044\u3066 \u653e\u5c04\u7dda\u7642\u6cd5\u306e\u63a8\u9032\u306b\u95a2\u3059\u308b\u7814\u4fee\u4f1a.\uff082016. 10, \u5b87\u548c\u5cf6\uff09
\n70.\u4e2d\u5cf6\u76f4\u7f8e. \u30b7\u30f3\u30dd\u30b8\u30a6\u30e0 Update on Breast Cancer Treatment. The role of regional nodal treatment in breast cancer. \u2013From radiation oncologists\u2019 view \u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a\u7b2c29\u56de\u5b66\u8853\u5927\u4f1a.\uff082016. 11, \u4eac\u90fd\uff09
\n71.\u7530\u4ee3\u3089\u307f. \u5fc3\u81d3\u30b5\u30eb\u30b3\u30a4\u30c9\u30fc\u30b7\u30b9 up to date. PET\u30b5\u30de\u30fc\u30bb\u30df\u30ca\u30fc2016 in \u718a\u672c\uff0e\uff082016. 8, \u718a\u672c\uff09
\n72.\u7530\u4e2d\u5b8f\u660e. AZUR\u30b3\u30a4\u30eb\u3092\u542b\u3081\u305f\u8840\u7ba1\u585e\u6813\u8853. \u7b2c1\u56de\u56db\u56fdIVR\u7814\u7a76\u4f1a.\uff082016. 1, \u677e\u5c71\uff09
\n73.\u7530\u4e2d\u5b8f\u660e. \u585e\u6813\u7528\u30b3\u30a4\u30eb\u306b\u3064\u3044\u3066\u306e\u57fa\u672c\u4e8b\u9805\u3068\u5b9f\u969b. Peripheral Advanced Coil\u30c8\u30ec\u30fc\u30cb\u30f3\u30b0 2016. \uff082016. 7, \u795e\u5948\u5ddd\uff09
\n74.\u7530\u908a\u88d5\u8cb4. \u5fc3\u7b4b\u8840\u6d41\u5b9a\u91cf\u8a55\u4fa1\u306e\u6700\u65b0\u30c8\u30d4\u30c3\u30af\u30b9\uff08CT\u3001MRI\u3001NM\uff09. \u611b\u5a9b\u5fc3\u81d3\u6838\u533b\u5b66\u8ac7\u8a71\u4f1a.\uff082016.\u300010, \u677e\u5c71\uff09
\n75.\u6771\u91ce\u535a. \u7dcf\u8ad6. \u7b2c10\u56de\u65e5\u672c\u5fc3\u81d3\u6838\u533b\u5b66\u4f1a \u4e2d\u56db\u56fd\u5730\u533a \u5730\u57df\u5225\u6559\u80b2\u7814\u4fee\u4f1a.\uff082016. 9, \u5009\u6577\uff09
\n76.\u5e73\u585a\u7fa9\u5eb7. \u8eab\u8fd1\u306a\u75c7\u4f8b\u304b\u3089\u898b\u308b\u982d\u90e8\u753b\u50cf\u306e\u6b63\u5e38\u3068\u7570\u5e38. \u7b2c18\u56de\u6771\u4e88\u653e\u5c04\u7dda\u79d1\u533b\u4f1a. \uff082016. 1, \u4eca\u6cbb\uff09
\n77.\u5e73\u585a\u7fa9\u5eb7. \u982d\u90e8\u753b\u50cf\u8a3a\u65ad\u306e\u81e8\u5e8a\uff1a\u4ee3\u8868\u7684\u75be\u60a3\u306e\u753b\u50cf\u7684\u7279\u5fb4\u3068\u6c17\u3092\u3064\u3051\u305f\u3044\u30dd\u30a4\u30f3\u30c8. \u4eca\u6cbb\u5e02\u6280\u5e2b\u7814\u7a76\u4f1a.\uff082016. 5, \u4eca\u6cbb\uff09
\n78.\u5e73\u7530\u96c5\u662d. \u30cf\u30f3\u30ba\u30aa\u30f3\u30bb\u30df\u30ca\u30fc CT\u30ac\u30a4\u30c9\u4e0b\u7a7f\u523a\u652f\u63f4\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u306e\u958b\u767a. \u7b2c2\u56de\u65e5\u672c\u7a7f\u523a\u30c9\u30ec\u30ca\u30fc\u30b8\u7814\u7a76\u4f1a.\uff082016. 5, \u5927\u962a\uff09
\n79.\u6ff1\u672c\u6cf0. \u77e5\u3063\u3066\u304a\u304d\u305f\u3044\u653e\u5c04\u7dda\u6cbb\u7642\u306e\u6700\u65b0\u60c5\u5831. NPO\u6cd5\u4eba\u611b\u5a9b\u304c\u3093\u30b5\u30dd\u30fc\u30c8\u304a\u308c\u3093\u3058\u306e\u4f1a\u4e3b\u50ac\u8b1b\u6f14\u4f1a\uff0e\uff082016. 6, \u677e\u5c71\uff09
\n80.\u6ff1\u672c\u6cf0. \u80ba\u304c\u3093\u6cbb\u7642\u306e\u6700\u524d\u7dda\uff1a\u80ba\u304c\u3093\u306f\u3069\u3046\u3059\u308c\u3070\u6cbb\u308a\u307e\u3059\u304b\uff1f \u7b2c47\u56de\u30d8\u30eb\u30b9\u30a2\u30ab\u30c7\u30df\u30fc\uff0e\uff082016. 7, \u677e\u5c71\uff09
\n81.\u6ff1\u672c\u6cf0. \u80ba\u764c\u306e\u653e\u5c04\u7dda\u6cbb\u7642. \u7b2c8\u56de\u4e2d\u30fb\u56db\u56fd\u653e\u5c04\u7dda\u6cbb\u7642\u590f\u5b63\u30bb\u30df\u30ca\u30fc.\uff082016. 7, \u5e83\u5cf6\uff09
\n<\/a>\u25a0<\/span> \u7814\u7a76\u52a9\u6210<\/strong>
\n1.\u5175\u982d\u670b\u5b50, \u6751\u4e0a\u5353\u9053. \u65e5\u672c\u5b66\u8853\u632f\u8208\u4f1a\u3000\u79d1\u7814\u8cbb \u57fa\u76e4\u7814\u7a76(C) \u7814\u7a76\u8ab2\u984c\u756a\u53f7\uff1a16K10369. \u300c\u809d\u52d5\u8108\u5316\u5b66\u585e\u6813\u7642\u6cd5\u306b\u304a\u3051\u308b\u30c7\u30e5\u30a2\u30eb\u30a8\u30ca\u30b8\u30fc\uff23\uff34\u3092\u7528\u3044\u305f\u5b9a\u91cf\u7684\u6cbb\u7642\u52b9\u679c\u5224\u5b9a\u300d 2016\u5e744\u6708-2019\u5e743\u6708
\n<\/a>\u25a0<\/span> \u53d7\u8cde<\/strong>
\n1.Yuki Tanabe. ECR 2016 Certificate of Merit Award. ECR 2016. (2016. 3, Vienna, Austria)
\n2.Naomi Nakajima. Poster Presentation Winners. Asian Oncology Summit 2016. (2016.5, Kyoto, Japan)
\n3.Masaaki Hirata. Magna Cum Laude. CIRSE 2016. (2016. 9, Barcelona, Spain)
\n4.\u7530\u4ee3\u3089\u307f. \u5e73\u621027\u5e74\u5ea6\u611b\u5a9b\u5927\u5b66\u5927\u5b66\u9662\u533b\u5b66\u7cfb\u7814\u7a76\u79d1\u9577\u512a\u79c0\u8ad6\u6587\u8cde \u512a\u79c0\u8cde. (2016. 3)
\n5.\u57ce\u6238\u8f1d\u4ec1. Best Paper Award 2015 \u6700\u512a\u79c0\u8ad6\u6587\u8cde. \u65e5\u7368\u533b\u5831. (2016. 4, \u6a2a\u6d5c)
\n6.\u5c0f\u5ddd\u907c. \u75c7\u4f8b\u8cde\u91d1\u8cde. SCMR JAPAN WG Seminar. (2016. 7, \u6771\u4eac)
\n7.\u57ce\u6238\u502b\u4e4b. 2016 most impressive article. SCMR. (2016. 12)<\/p>\n","protected":false},"excerpt":{"rendered":"

2016\u5e74\u696d\u7e3e\u3000\u305d\u306e2 \u25a0\u3000\u5b66\u4f1a\u30fb\u7814\u7a76\u4f1a\u767a\u8868 \u56fd\u5185\u5b66\u4f1a\uff08\u5168\u56fd\uff09 \u56fd\u5185\u5b66\u4f1a\uff08\u5730\u65b9\u4f1a\uff09 \u25a0 \u8b1b\u6f14 \u25a0 \u7814\u7a76\u52a9\u6210 \u25a0 \u53d7\u8cde \u8ad6\u6587\u3001\u56fd\u969b\u5b66\u4f1a\u767a\u8868\u306f2016\u5e74\u696d\u7e3e\u3000\u305d\u306e1\u3092\u3054\u89a7\u4e0b\u3055\u3044\u3002 ———& […]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[20],"tags":[],"class_list":["post-3474","post","type-post","status-publish","format-standard","hentry","category-20"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.m.ehime-u.ac.jp\/school\/radiology\/wp-json\/wp\/v2\/posts\/3474","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.m.ehime-u.ac.jp\/school\/radiology\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.m.ehime-u.ac.jp\/school\/radiology\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.m.ehime-u.ac.jp\/school\/radiology\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.m.ehime-u.ac.jp\/school\/radiology\/wp-json\/wp\/v2\/comments?post=3474"}],"version-history":[{"count":0,"href":"https:\/\/www.m.ehime-u.ac.jp\/school\/radiology\/wp-json\/wp\/v2\/posts\/3474\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.m.ehime-u.ac.jp\/school\/radiology\/wp-json\/wp\/v2\/media?parent=3474"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.m.ehime-u.ac.jp\/school\/radiology\/wp-json\/wp\/v2\/categories?post=3474"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.m.ehime-u.ac.jp\/school\/radiology\/wp-json\/wp\/v2\/tags?post=3474"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}